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Summary
This thesis presents a multifaceted approach which comprehensively describes the design of novel drug 
delivery polymeric complexes through the application of innovative crosslinking reactions. These 
reactions have been built on the statistical and mathematical principles governing the technique of 
Design of Experiments. At the outset, pertinent aspects covering the importance of rate-controlled drug 
delivery in achieving superior therapeutics is presented. In addition, the fundamental mechanisms 
which regulate the complex behaviour of polymeric materials are outlined, placing emphasis on the 
mathematical models which demonstrate the critical need to be able to synchronize the processes of 
matrix hydration, relaxation, disentanglement, erosion and dissolution. Initially, the Plackett-Burman 
Design was evaluated to develop a crosslinked polymeric oilisphere device for the in vitro site-specific 
delivery of Mentha piperita oil. This design proved to be highly successful in rapidly identifying the 
appropriate release rate-modifying variables through the application of stepwise regression optimization 
and Artificial Neural Networks. Having assessed the utility of Design of Experiments and receiving 
positive feedback on its predictive power over the physicochemical and physicomechanical properties of 
the crosslinked matrices, the study progressed into the design and development of a novel zinc- 
alginate-pectinate complex based on a statistical combination of independent variables derived from a 
high resolution quadratic Box-Behnken Design. All studies from this point onwards employed either 
ibuprofen or theophylline as model drugs. Based on the response outcomes for matrix resilience, 
rupture energy, yield value, viscoelasticity, drug encapsulation efficiency and dissolution, it became 
evident that a greater degree of crosslinking was achieved in the case of the zinc-pectinate complex. 
This study did not aim to undertake numerical optimization on the experimental output, but rather to 
select a candidate formulation based on specific constraints, for further manipulation. In order to 
manipulate the stress-strain properties and drug releasing potential of the candidate zinc-pectinate 
system, a novel crosslinked ethylenic homopolymer was synthesized. This synthesis was also based on 
a Box-Behnken Design, which allowed for stringent mathematical optimization of the new polymeric 
material. This material, synthesized through a unique combination of organic and inorganic crosslinkers, 
is the first to be reported in this study. Incorporation and evaluation of the crosslinked ethylenic 
homopolymer within the candidate zinc-pectinate matrix was based on a Face-Centred Central 
Composite Design, which ultimately led to the development of a range of optimized dissolution profiles 
capable of drug delivery in a zero-order manner over several hours to days, either with or without a lag- 
phase.
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Chapter One
Rate-Controlled Drug Delivery: Importance and Key Principles
1.1 Introduction
The control of the intensity and the duration of drug action have been of interest to 
pharmaceutical scientists for many years. However, only recently has this technology 
been exploited commercially to a large extent. This new generation technology has led to 
more complex mechanisms used for rate-modulation of bioactives.
The advantages resulting from modulation of drug action include, the maintenance of 
therapeutic effect over an extended period of time, especially if a continuous action at a 
therapeutic level is essential (Praveen, 1990; Danckwerts, 1996; Pillay and Fassihi, 
2002a).
Another important advantage is the convenience offered to the patient by this type of 
design due to the decrease in dosing frequency (increased patient compliance). 
Optimization of drug action, including drug safety, may also be handled by controlling the 
rate of drug delivery to the physiological absorption surfaces.
In practice, controlled drug release products are frequently necessary for chronic drug 
administration such as in the case of calcium channel blockers (nifedipine and diltiazem) 
and beta adrenergic blockers (propranolol and metoprolol) for the management of angina 
and hypertension. This does not preclude the application of other pharmacological drug 
classes in the design and development of advanced drug delivery systems.
The ideal attributes of a rate-modulated drug delivery system include:
(i) Flexible programming: Ability to accommodate the pharmacokinetics of various
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drugs,
(ii) Precise programming: Capability of precise control for a constant delivery rate,
(iii) Relatively insensitive to the physiological variables such as gastric motility and rate 
of emptying, gastrointestinal pH, fluid volume, and content, absence/presence and 
concentration of enzymes, absence/presence of food, physical position and activity 
of subject, individual variability and pre-existing/new disease states,
(iv) Predictable rate of delivery based on physicochemical principles,
(v) Capable of a high level of drug dispersion,
(vi) Maintenance or enhancement of drug stability,
(vii) Controlling mechanism does not significantly affect the mass of the dosage form, 
and
(viii) Applicable to a wide range and variety of drugs, chemicals, proteins, 
macromolecules, vaccines, hormones and other bioactives.
There are numerous factors that affect the in vivo performance of controlled release
formulations and these include:
(i) Physiological Factors:
(a) Prolonged drug absorption,
(b) Size of absorption window, and
(c) Gastrointestinal blood flow and degree of perfusion.
(ii) Biopharmaceutic and Pharmacokinetics Factors:
(a) Effect of gastrointestinal pH on drug release rate,
(b) First pass metabolism,
(c) Variability in urinary pH and effect on drug elimination, and
(d) Enzyme induction/inhibition upon multiple dosing.
18
(iii) Pharmacologic Factors:
(a) Change in drug effect upon multiple dosing,
(b) Sensitization/tolerance, and
(c) Change in metabolic profiles, if active metabolites are present.
1.2 Clinical Aspects of Novel Drug Delivery Systems
The clinical rationale for the development of novel drug delivery systems is to achieve 
safer, more efficacious therapy, and to promote patient compliance by decreasing the 
cost and increasing the ease of use. The sophistication in pharmaceutical research 
required to achieve these objectives is multidisciplinary and requires an understanding of 
the pathophysiology of disease, knowledge of the pharmacokinetics, pharmacodynamics 
and physicochemical properties of the drug (Turner, 1990).
With continued advances in understanding the molecular basis of diseases, it may be 
possible to identify the precise biochemical defect present in each patient. With this 
knowledge and the development of novel drug delivery systems, it may be possible to 
target specific therapeutic agents in order to provide safer and more efficacious 
therapeutics. Progress is continually being made along these lines in several clinical 
disciplines such as gene therapy and encapsulation of DNA and plasmid vectors (Perez 
et al., 2003).
1.3 Technology Applied in this Study
Hydrophilic swellable polymers used in the development of drug delivery devices in their 
native state, usually demonstrate rapid gelation, first-order dissolution, and non- 
synchronized erosion/relaxation in relation to the timescale required for modulated drug 
delivery (Pillay and Danckwerts, 2002). In their study, these researchers have shown that 
these limitations can be significantly solved through the process of chemical crosslinking 
and salting-out which essentially changes the extent of polymer entanglement and hence
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the rate of disentanglement.
Recent work has shown that through the use of specific formulation excipients, the 
inherent properties of certain polymeric materials may be altered in situ for the provision 
of specific release profiles (Pillay and Fassihi, 1999a; 2000a; 2000b). The effects 
resulting from salting-out and complexation of polymers induced through chemical 
crosslinking may include phase transitions within the gel microstructure, alteration of 
water mobility rates and changes in the degree of polymeric dehydration (Pillay and 
Danckwerts, 2002).
The increase in the glass transition temperature (Tg), and the mobility of polymeric chains 
is significantly reduced and thus, in conjunction with crosslinking and salting-out 
phenomena, overall solubility of the polymeric system may be reduced. Crosslinks tend 
to create three-dimensional voids or pockets within the polymeric matrix and hence, 
diffusion of the imbibed medium becomes more restrained, thereby controlling matrix 
relaxation and erosion. These effects may potentially influence the nature of an already 
complex hydrated polymeric system, and subsequently the regulation of drug transport 
(Pillay and Danckwerts, 2002).
1.4 Motivation for the Present Study
We have recently identified in our laboratory at the University of the Witwatersrand, 
Department of Pharmacy and Pharmacology, that the salting-out/crosslinking of polymers 
such as polyvinyl alcohol (PVA), alginate and pectin, induced in a very novel and specific 
manner, may be particularly advantageous for the achievement of rate-adjusted drug 
delivery through the development of modified intelligently-reacting polymers (Pillay, 2002).
It is the objective of this research to investigate the specificity and applicability of this 
crosslinking process which to date has not been elucidated in biomedical research as a
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potential approach for drug delivery. For example, this crosslinking process provides 
modified matrices which are brittle in the unhydrated state, plastic to pseudoplastic in the 
hydrated state and low to highly soluble but gellable with superswellable properties. This 
approach of polymeric crosslinking allows for the formation of discrete spherical, elliptical 
and disk-shaped entities termed “gelispheres” or “oilispheres” depending on the 
encapsulated bioactive agent and rate-modulating mechanism.
Various formulation strategies will be adopted to develop novel drug delivery systems with 
the aim of achieving steady-state release.
1.5 Overall Aim and Objectives of this Study
1. Application of Experimental Design to develop statistically and mathematically 
robust combinations of experimental formulations,
2. Synthesis of crosslinked polymers using the above designs by ionotropic gelation,
3. Physicochemical and physicomechanical analysis of crosslinked matrices 
employing several approaches:
(i) In vitro dissolution studies,
(ii) Polymer gravimetric transitions,
(iii) Bioactive encapsulation efficiency,
(iv) Textural profiling analysis,
(v) In situ viscoelastic transitions of sequentially crosslinking polymer 
solutions,
(vi) Particle size analysis of crosslinked entities,
(vii) Mathematical and kinetic modelling of experimental data,
(viii) Predictive power of Artificial Neural Networks,
(ix) Differential Scanning Calorimetry (DSC),
(x) Fourier Transform Infra-Red Spectroscopy (FTIR), and
(xi) X-ray Diffraction (XRD).
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Chapter Two
Fundamentals of Drug Delivery Systems Design
2.1 Introduction
Hydrogels are typically polymeric materials that absorb a significant amount of water 
(>20% of their dry weight) while maintaining a distinct three-dimensional structure 
(Cascone et al., 1995). This definition encompasses both dry polymers that swell when 
placed in water and pre-swollen elastic materials.
In recent years, there has been an explosion in the interest of polymer-based delivery 
devices. Such devices can enhance drug stability by protecting labile drugs from 
denaturants in the body, control the release rate of therapeutic agents and help achieve 
site-specific delivery, as in the case of colonic drug-targeting.
These polymeric materials possess four key properties: differential rates of gelation, 
permeability, swelling, and biocompatibility (Cascone et al., 1995). Their ability to retain 
high water content provides excellent biocompatibility since impurities can be easily 
extracted. Their soft, rubbery nature reduces mechanical irritation. In addition, their 
hydrophilic character minimizes interfacial tension. Very often the permeability of 
hydrogels to water, drugs, and other solutes are adjusted over a broad range by changing 
the gel precursor, crosslinker, or conditions of synthesis in order to modulate drug 
transport within the gel and hence drug delivery.
The reproducible and controllable swelling kinetics of hydrogels are a result of their time- 
dependent permeability dynamics which allow therapeutic agents to be delivered in a 
prescribed manner.
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2.2 Thermodynamic Phenomena of Hydrogels
2.2.1 Equilibrium Swelling
While permeability characteristics and biocompatibility are desirable properties of 
hydrogels, they usually demonstrate low mechanical strength.
The amount of water absorbed is a function of the hydrophilicity of the polymer, the 
network structure and the number of ionized groups on the polymer. The basic swelling 
theory assumes that swelling of the hydrogel is a result of several independent free- 
energy changes which occur when the gel is mixed with a solvent as seen in Equation 
2 . 1.
A G f 0 /  —  ^Gmjx AGeias ^Gjons ~f~ AGelec (Equation 2.1)
where AGtot = total free energy change, AGmix = mixing of polymer chains with solvent 
molecules, AGeias = elastic response to changes in the configuration of the polymeric 
network, AGions= mixing of ions from solution and from the polymer with the solvent, and 
AGeiec = changes in electrostatic interactions of ionized groups upon swelling (Lai et al., 
2000).
It is conceptually more convenient to convert the free-energy terms to osmotic swelling 
pressures, using thermodynamic relations. The Flory-Huggins Theory can also be used 
to calculate the enthalpy and entropy changes associated with laying out a polymer chain 
on a lattice by applying the Flory-Huggins interaction parameter, which indicates the 
degree of interactions between solvent and the polymer molecules. Interaction 
parameters are generally between 0 and 1 when polymer-solvent interactions dominate, 
and dissolution is favoured.
2.2.2 Permeability
While equilibrium swelling may be a key characteristic of the hydrogel, its permeability
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makes it highly attractive for drug delivery. Hydrogels can be rendered impermeable, 
semipermeable or highly permeable to virtually any class of solute and hence applicable 
to a wide variety of drug delivery problems e.g. drug solubility limitations.
Two basic mechanisms, namely the "pore” and “partition” theories are assumed to explain 
solute diffusion through hydrogels. In the "pore" mechanism, the solute moves only 
through water-filled regions of the gel, whereas in the "partition” mechanism, solute 
transport is assumed to involve thermodynamically-controlled dissolution into the polymer.
One of the early models used to interpret diffusion through polymer networks was that 
proposed by Yasuda and Rosengren (1971). These researchers introduced a free- 
volume theory which assumes that the solute moves only within water-filled regions of the 
gel. The diffusion coefficient is proportional to [exp(-Vs/Vf)], where Vs is the characteristic 
volume of the solute and V, is the free volume inside the gel. The free volume V, is 
assumed to be linearly related to the weight fraction of water inside the gel. Combining 
these relationships results in the following:
Log (Dg) = Log (D0) -  k/(q-1) (Equation 2.2)
where Dg = diffusion coefficient of the solute in hydrogel, D0 = diffusion coefficient of the 
solute in solvent, k = constant solute volume and the free volume of water, and q = 
degree of swelling.
2.2.3 Swelling Kinetics
The third major property of hydrogels is their controllable swelling kinetics. Since the 
solute permeability is directly related to the degree of swelling, control of swelling leads to 
control of the solute permeability, and hence drug release.
The relative importance of relaxation and diffusion, can in principle be estimated from the
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Deborah Number, De (Reiner, 1969), where:
De = Time of Relaxation/Time of Observation (Equation 2.3)
Thus when De« 1 ,  relaxation is faster than diffusion and Fickian diffusion is observed. 
This occurs well above the glass transition temperature (Tg), where gels are rubbery and 
the diffusion coefficient is generally a strong function of concentration. Fickian diffusion in 
a constant manner is observed for De» 1 . This corresponds to diffusion which occurs in a 
glassy polymer well below Tg, where polymer relaxation is slow and its structure is 
unchanged by the diffusion process (hence the gel does not swell in this region). When 
De=1, relaxation and diffusion interact, leading to transport not explained by Fickian 
diffusion (non-Fickian or anomalous transport).
2.3 Microsphere Technology in Rate-Modulated Drug Delivery
Particles applied in drug delivery in the range from 100nm-1pm are termed microspheres. 
Those smaller than this are termed nanoparticles (Juliano, 1980; Chawla et al., 2000).
Drugs with a range of water solubilities can be incorporated into microspheres by 
including them in polymer solutions using various techniques outlined below. Substantial 
interest in the application of polymer-based microspheres as drug carriers results from 
their ability to regulate drug release rates and more importantly their ability to produce 
desirable biopharmaceutical characteristics (Widder et al., 1982, Soppimath et al., 2001).
2.3.1 Advantages of Microspheres
(i) Predictable Gastrointestinal Transit Times:
After ingestion of an oral non-disintegrating dosage form, it resides in the stomach for an 
unpredictable time. To understand the implications of this initial state of the 
gastrointestinal transit, it is important to mention the role of the stomach in terms of its
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anatomical structure and motor functioning either during the interdigestive or digestive 
phases, a phenomenon referred to as the Migrating Myoelectric Complex (MMC) 
(Mojaverian, 1991; Davis etal., 1986).
During the interdigestive phase, the empty stomach displays a cyclic motion that can be 
divided into four phases as follows:
(a) Phase 1: An inactive quiesant phase with little or no contractions which lasts up to 60 
minutes,
(b) Phase 2: Consists of irregular and intermittent sweeping contractions,
(c) Phase 3: Comprised of acute eruptions of peristaltic waves in the proximal and distal 
gastric areas, lasting between 5 and 15 minutes. This phase empties the stomach 
contents and indigestible debris. This explains why it is almost impossible to prolong the 
residence of multiple-unit systems (e.g. microspheres) in the stomach (Harris and 
Robinson, 1990), and
(d) Phase 4: The transient period of decreasing activity until the next cycle.
Single-units are retained in the stomach until Phase 3 of the MMC returns. Thus after a 
meal, the pylorus appears to act as a sieve allowing small particles to filter through but 
retaining larger particles (Muller and Blum, 1981).
(ii) Independence from Cardiac and Pyloric Contraction/Relaxation Activities:
Highly soluble drugs administered within pellets, disperse in the gastric fluids and are 
emptied with food. Due to their small sizes, multiple-units easily pass through the cardiac 
and pyloric sphincters regardless of whether they are contracted or relaxed.
(Hi) Induce Less Localized Gastrointestinal Disturbances:
There is a reduction in local side-effects such as nausea, vomiting, abdominal pain, and 
gastric irritation due to the dispersive nature of multiple units.
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(iv) Achievement of Site-Specific Drug Delivery:
The biopharmaceutical, pharmacokinetic, and pharmacodynamic characteristics of a drug 
molecule often combine to largely reduce the drug molecule’s intrinsic activity. A simple 
equation illustrating this, is presented by Sahoo and co-workers (2002).
Observed Activity = Intrinsic Activity x Drug at Receptor (Equation 2.4)
Any process or phenomenon that reduces the amount (and frequency) of drug arriving at 
its pharmacological receptor will result in that molecule producing a lower observed 
therapeutic effect.
There are two potential directions that can be taken to improve (or optimize) the action of 
a drug. The first is the design of new biologically-active molecules which are both potent 
and selective for particular receptors such as the renowned “Ehrlich’s Magic Bullet” 
approach (Harris and Robinson, 1990).
The second option is the one employed in the present study, which involves the “Magic 
Missile” approach. This purports the use of carrier systems (“Missile Delivery”) that will 
target active molecules to specific sites in the body. Upon reaching the site, drug is 
released either passively or via a specific site-recognition event (Sahoo et al., 2002).
Thus targeted delivery is highly dependent on the physicochemical and biophysical 
interactions between multiple-units and the physiological system (Burczak et al., 1994).
The ideal characteristics of a targeted drug delivery system include:
(i) Restricted drug distribution to the target,
(ii) Prolonged control,
(iii) Ready access to tissue parenchyma,
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(iv) Controllable and predictable rate of drug release,
(v) High loading capacity for drugs and drug types,
(vi) Ideal therapeutic amounts of drug release,
(vii) Minimal drug leakage during transit to the target,
(viii) Drug protection,
(ix) Biocompatible surface properties,
(x) Biodegradable targeted delay systems, and
(xi) Ease of synthesis or formulation.
2.4 Techniques for the Preparation of Microspheres
2.4.1 Coacervation Phase Separation
Coacervation encapsulation (or microencapsulation) is a three-part process comprised of 
the formation of a droplet, coacervative wall and capsule.
Coacervation involves the separation of a liquid phase (coating material) from a polymeric 
phase and then wrapping this phase as a uniform layer around suspended core particles. 
Coacervation may be brought about when the surface energy between the core and 
coatings material are adjusted by varying some critical parameters of the system such as 
temperature, pH or composition. The coating material is then solidified by means of heat, 
crosslinking, or solvent removal techniques (Orienti et al., 2001; Meese et al., 2002).
The microcapsules are usually collected by filtration or centrifugation, washed with an 
appropriate solvent, and subsequently dried by standard techniques to yield free-flowing 
discrete particles.
Coacervation may also be subdivided into aqueous phase separation and non-aqueous 
phase separation techniques. This technique, also referred to as “oil-in-water” 
microencapsulation, has been used to encapsulate citrus oil, vegetable oil and vitamin A 
(Paradossi et al., 2002).
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Non aqueous (organic) phase separation also referred to as “water-in-oil” encapsulation, 
comprises a hydrophobic coating and a water-soluble or water-insoluble core. This 
process has been investigated for the encapsulation of solid food additives such as 
ferrous sulphate (Bolassa and Fanger, 1971).
The major disadvantage of coacervation is that even though it is efficient, it is also very 
expensive and difficult to scale-up.
2.4.2 Extrusion-Spheronization
This technique involves the formation of pellets coated with a candidate drug that can be 
filled into a capsule. Spheronization is a rapid method to produce spherical pellets of 
uniform size and shape as well as smooth surfaces. Spheronization enables the spraying 
of an even film coating. This technique is often used in the pharmaceutical industry for 
drug encapsulation and subsequent tableting of drug products.
The required conditions for this process are good deformation and binding properties of 
the material, and the ability to plastically deform. The technology of low pressure 
extrusion and spheronization is a fast procedure for continuous pelletization. The 
disadvantage of this technique is that it is a tedious process and requires specialized 
equipment.
One of the major techniques employed for the synthesis of hydrogels involves the 
formation of crosslinked linear or branched polymers using crosslinking reagents such as 
divalent/trivalent ions or ultraviolet light (Figure 2.1).
2.4.3 Crosslinking Technology
Crosslinks can be formed with many di-functional compounds capable of condensing with 
the pendant hydroxy groups contained within hydrophilic polymers. The reaction is
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normally carried out in solution, although suspension polymerization may also be used to 
form crosslinked matrices. The solvent is typically water, although other solvents such as 
alcohols can be used (Thanoo et al., 1992).
Figure 2.1 Schematic illustrating a typical crosslinking process (source: 
http://www.labsearch.org).
The extent to which the resulting gel is crosslinked is typically defined in terms of the 
nominal crosslink ratio, X (Ravve, 2000). This parameter is defined as the ratio of the 
moles of the crosslinking agent used to the moles of polymer repeating units present. A 
nominal number-average molecular weight between crosslinks, Mc, can be related to X as 
follows for di-functional crosslinkers:
Mc = Mr/2X (Equation 2.5)
where Mr is the molecular weight of the repeating unit.
When polymerization proceeds in a three-dimensional manner, some period after it has 
progressed to a certain threshold, gelation occurs. This well-defined transition during
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polymerization is known as the gel point and at this point the reaction mixture changes 
from a viscous liquid to an elastic gel (Ravve, 2000).
The present study extensively explores this method for the formation of “intelligent” 
polymeric materials.
2.5 Hydrational Dynamics within Polymers
Drugs administered should ideally be delivered at a predetermined rate into the systemic 
circulation. If the delivery rate is lower than this ideal rate, the drug-plasma level may be 
below the minimum effective concentration (MEC). On the other hand, if the delivery rate 
is above this ideal rate, there is a risk of central and local effects. This may even lead to 
toxic effects due to the drug-plasma level spiking above the maximum safe concentration 
(MSC) (Figure 2.2a,b).
Essentially, drugs should be delivered at a constant rate for the attainment of zero-order 
kinetics. Over the years, several mechanisms have been studied to obtain zero-order 
kinetics, including osmosis, erosion, diffusion, swelling and/or a combination of these 
processes (Davis et al., 1986; Colombo et al., 1987).
In addition, various physical designs have been developed, namely bilayer and triple layer 
technology (Colombo et al., 1987). In the case of swelling-controlled systems polymeric 
matrices are loaded with drug uniformly dispersed within the matrix.
In the case of partially or completely crosslinked systems, strong secondary bonds with 
such aqueous media. Water in effect acts as a plasticizer and lowers the Tg of the glassy 
polymer below room temperature and hence converts it into its rubbery state.
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Figure 2.2 Drug plasma concentration-time curve after the administration of (a) 
Eight, and (b) Three equal oral doses (MSC = Maximum Safe Concentration; MEC 
Minimum Effective Concentration) (source: 
http://www.as.dmu.ac.uk/pharmscape/tour_6.htm).
As the water diffuses into the polymeric matrix a boundary is formed, namely the swelling 
front. This front separates the glassy phase from the rubbery phase. Within the rubbery 
phase, the matrix contains both dissolved and undissolved drug. The boundary between 
these entities is referred to as the diffusion front. In addition, there is an erosion front at 
the peripheral surface as the polymer subsequently erodes.
2.5.1 The Homogeneous Swelling Model
This model proposed by Siepmann and co-workers (1999) employs diffusion to simulate 
water penetration into the matrix. Based on the concentration profile at an instantaneous 
time, an estimate of the volume of water within the matrix can be calculated. The total 
volume is assumed to be the sum of the initial polymer volume and the calculated volume 
of water. In this model, the entire polymer swells even if water has only penetrated a 
short distance into the matrix.
2.5.2 The Sequential Layer or Non-Homogeneous Swelling Model
In a more recent model by Siepmann and Peppas (2001), a variation of the above 
homogeneous model is proposed. The assumption is that the polymer matrix is 
composed of a series of sequential layers which swell one after the other, as in the case 
of the homogeneous model. Both of these models assume the existence of a 
concentration-dependent diffusion gradient for water.
However, an ideal model should account for the occurrence of simultaneous swelling, 
diffusion and erosion which provides a way to simulate non-instantaneous drug 
dissolution by modelling a dissolution zone between the swelling and diffusion fronts, and 
not having to make assumptions about homogeneous or heterogeneous swelling (Yang 
and Fassihi, 1997).
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2.5.3 The Power Law Model
This equation describes the diffusion of drug through polymeric materials (Ritger and 
Peppas, 1987):
M/Mo =k1 f  (Equa tion 2.6)
where M, and M. are the amounts of drug released at time t and the total amount of drug 
within the polymer, k! is a release constant and n is a release exponent indicative of the 
profile shape.
2.5.4 The Peppas-Sahlin Model
This model (Peppas and Sahlin, 1989) accounts for polymer matrices that undergo both 
diffusion and relaxation during drug release. The release kinetics of the drug is explained 
by the following mathematical expression:
M,/M~ = k i f  + k2f n (Equation 2.7)
where in this case k2 is a relaxation constant.
2.5.5 The Hopfenberg Model
This model (Hopfenberg, 1976) was developed for polymeric matrices exhibiting surface 
erosion. Essentially polymers erode by two distinct mechanisms, bulk erosion and 
surface erosion. In surface erosion, the rate at which the polymer transforms into a water- 
soluble material is more rapid than the rate at which water penetrates into the polymer. 
This means that the device thins out but still maintains its structural integrity (Katzhendler 
et al., 1997). In this model drug release from erodible slabs, cylinders, and spheres are 
described as follows:
M,/M~ = 1 - ( 1  - K,t)n (Equation 2.8)
where in this case Kt is an overall erosion rate constant.
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2.6 Criteria for Determination of Model Suitability
In practical data analysis, it is always unclear which as to which model provides the best 
fit. The general tendency is to use familiar functions, but their accuracy and applicability 
may be questionable.
In this work, the fit of data to the above models were determined by the Akaike 
information Criterion (AIC), Schwartz Criteria (SC), and Condition Number (CN). Pillay 
and Fassihi (1999a) have detailed the importance of these three critical parameters in the 
selection of appropriate model fitting.
35
Chapter Three
Design of Experiments; A Statistical and Mathematical Approach to 
Optimization of Function Variables
3.1 Introduction
Experimental design is one of the first and most important stages of any scientific study. 
It helps in constructing a precise mathematical description of the process in the region of 
experimentation through conducting a statistical analysis and finally selecting the shortest 
path to process optimization (Hendrix, 1979; Semval, 1997; Schwartz et al., 2002).
This is the stage where questions like what factors influence product yield, what 
parameters determine product purity, what variables or conditions are responsible for the 
outcome of a given test and what is their precision, are asked.
Pharmaceutical formulation and process problems are normally characterized by multiple 
objectives. In designing a pharmaceutical product, for example, the scientist must often 
meet pre-set control limits, which define or influence such a dosage form, for example unit 
cost, physical stability, chemical stability, or bioavailability of the active ingredient.
The parameters describing these dosage form characteristics represent response or 
dependent variables, and any limits or conditions placed on these response variables 
represent the objectives. The magnitude of the observed value for each response 
variable generally depends upon levels of one or more of the controllable (independent) 
variables.
3.2 Selection of the Design
Selection of an appropriate experimental design depends on the objectives of the
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experiment and the number of factors to be investigated.
Since laboratory experimentation is often very expensive and time consuming, planning of 
an optimum number of experiments is crucial. The statistical design of experiments is a 
procedure for conducting the minimum number of trial experiments for obtaining the 
optimal conditions of the variables or factors for a response. The levels of a factor range 
from low to high.
Some known techniques of statistical experimental design are Factorial Analyses, 
Plackett-Burman Matrices and Response Surface Methods, but the most commonly 
employed approach is the Factorial Analysis at two levels (2N). The two-level Factorial 
Design allows for an evaluation of N variables and their interactions, by changing them at 
two levels (low and high). The statistical analysis of the results allows for the 
determination of their significance and the determination of an experimental equation 
which associates the variables with the results. Flowever, with an increase in the number 
of experiments, the increased output of useful information may be doubtful. This is due to 
the fact that the third and higher order interactions are generally statistically and 
physically insignificant, hence the choice of Fractional-Factorials instead of Full-Factorials 
are often selected (Gohel and Amin, 1999).
3.3 Experimental Design Objectives
3.3.1 Comparative Objective
If one or several factors are under investigation, but the primary goal of the experiment is 
to make a conclusion about one a-priori factor (in the presence of, and/or existence of 
other factors), the question of interest is whether or not that factor is “significant". This 
therefore, is a comparative problem requiring a comparative design solution, which ideally 
is a linear model (e.g. Factorial Design).
3 7
The primary purpose of the experiment is to select or screen out the few important main 
effects from many less important ones. The Screening Designs are also termed main 
effect designs (e.g. Plackett-Burman) and are described by linear models.
3.3.2 Screening Objective
3.3.3 Response Surface Objective
This high resolution design is employed to estimate interactions and quadratic effects, 
and therefore provides an idea of the (local) shape of the response surface under 
investigation. Hence such designs termed Response Surface Methods. These methods 
are used to:
(i) Find improved or optimal process settings,
(ii) Troubleshoot process problems and weak points, and
(iii) Make a product or process more robust against external and non-controllable 
influences (robust meaning relatively insensitive to these variables).
3.3.4 Optimal Fitting of a Regression Model Objective
This is for modelling a response as a mathematical function (either known or empirical) of 
a few continuous factors. This provides “good” model parameter estimates (i.e. unbiased 
and minimum variance).
3.4 Design Selection
Table 3.1 Criteria for Selection of an Experimental Design
Number of 
Factors Comparative Screening/Factorial
Response
Surface
1 1-Factor completely 
randomized design
None None
2-4 Randomized block design Full Factorial (a) Central 
Composite 
(b) Box-Behnken
>5 Randomized block design (a) Plackett-Burman None
38
3.4.1 Types of Factorial Designs
3.4.1.1 Full-Factorial Design
This design tries every possible combination of all the parameters under investigation. 
The disadvantage of this method is that the number of experiments may be too large and 
hence too costly. There are three ways to solve the above problem namely, reduce the 
number of levels of each parameter, reduce the number of parameters, or use a 
Fractional-Factorial.
3.4.1.2 Fractional-Factorial Design
This is a Factorial experiment in which only an adequately chosen fraction of the 
treatment combinations required for the complete factorial experiment is selected. This 
technique is often used for product and process design as well as process 
troubleshooting. Based on the result of fractional experiments, input factors can be 
identified and then investigated more thoroughly in subsequent high resolution designs.
3.4.2 Types of Response Surface Methods
Response Surface Methods are based on the fundamental assumption that the influence 
of the random input variables on the random output parameters can be approximated by a 
mathematical function. Hence, Response Surface Methods locate the sample points in 
the space of random input variables such that an appropriate approximation function can 
be found most efficiently; typically, this is a quadratic polynomial. Therefore, a Response 
Surface analysis consists of two steps:
(i) Performing the simulation loops to calculate the values of the random output 
parameters that correspond to the sample points in the space of random input 
variables, and
(ii) Performing a regression analysis to derive the terms and the coefficients of the 
approximation function.
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The fundamental idea of Response Surface Methods is that once the coefficients of a 
suitable approximation function are found, one can directly use the approximation function 
instead of looping through the finite model elements.
3.4.2.1 Central Composite Design
These types of experimental designs are variants of the Response Models of the second 
order. The design consists of three types of points namely, axial points (2N axial points 
are created by a screening analysis), cube points (2N cube points are derived from a Full- 
Factorial Design), and centre points (points in the centre are created by a nominal 
design). There are three types of Central Composite Designs (Figure 3.1) namely, 
Central Composite Circumscribed (CCC), Central Composite Inscribed (CCI) and Central 
Composite Face-Centred (CCF). The CCD is used to determine the coefficients of a 
second-order Response Surface Model. The advantage is that a small number of 
experiments are required. The CCI and CCC are also rotable designs and are preferred 
when model evaluations are expensive.
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Figure 3.1 Statistical points of a Central Composite Design (source: 
http://www.jmp.com/product/design_of_experiments/optimum.shtml).
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3.4.2.2 Box-Behnken Design
This design does not have simple matrix generators; instead it is constructed by 
combining two-level Factorials with incomplete block designs. It also has complex 
confounding of interactions. The design is economical and therefore particularly useful 
when it is expensive to perform necessary experimental runs.
3.4.2.3 Advantages of Response Surface Methods
(i) They often require fewer simulation loops than a Monte Carlo Simulation method,
(ii) They can evaluate low probability levels,
(iii) The goodness-of-fit parameters provide a good approximation function as to how 
accurate the approximation function describes the “true” response parameter 
values. The goodness-of-fit can provide a warning of when the approximation 
function is insufficient, and
(iv) The individual simulation loops are inherently independent. This makes the 
Response Surface Method an ideal candidate for parallel processing.
3.4.2.4 Disadvantages of Response Surface Methods
(i) The number of required simulation loops depends on the number of random input 
variables, implying that if there is a large number of random input variables then a 
probabilistic analysis would be impractical, and
(ii) These methods are not suitable for cases where a random output parameter is a 
non-smooth function of the random input variables.
3.4.3 Types of Screening Designs
The screening analysis creates 2N sample points. These points are defined by the rule 
that one of the parameters has a minimum or maximum value, while all other parameters 
have nominal values.
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3.4.3.1 Plackett-Burman Design
An example of a screening technique is the Plackett-Burman Design shown below:
Figure 3.2 Statistical points of a Plackett-Burman Design.
When one requires to screen a large number of factors to identify those that may be 
important (i.e. those that are related to the dependent variables of interest), one should 
employ a design that allows one to test the largest number of main factor effects with the 
least number of observations. Such designs confound all interactions with new main 
effects. Hence such designs are sometimes called saturated designs, since all 
information in those designs is used to estimate the parameters, leaving no degrees of 
freedom to estimate the error term for the analysis of variance (ANOVA). Therefore, this 
approach provides efficient estimations, ignores interactions and is used in a matrix form.
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Chapter Four
Testing the Utility of a Two-Level Screening Design for the Formulation and 
Optimization of a Novel Crosslinked Delivery System for Mentha piperita Oil
4.1 Introduction
Irritable bowel syndrome (IBS), a functional disorder of the intestines, is characterized by 
severe abdominal cramps and constipation with alternating periods of diarrhoea. 
Population-based studies in the United States estimate the prevalence of IBS at 10-20% 
and the incidence at 1-2% per year. An estimated 20-50% of gastroenterology referrals 
relate to this symptom-complex (Madden and Hunter, 2002).
The primary cause of IBS appears to be related to altered intestinal motility patterns. 
Patients experience rigid contractions and pain in the bowel, which are responsible for the 
sensation of bloating, discomfort, and urgency, a symptom-complex also enforced by the 
hypothesized “brain-gut-axis” theory (Allescher, 2003; Dunn et al., 2003). In general, 
smooth muscle relaxants are beneficial in the treatment of abdominal pain associated with 
IBS. Over the years many drug classes have been used for the alleviation of IBS 
symptoms, including antidiarrhoeals, antiflatulants, anticholinergics, opiates, low-dose 
antidepressants and most recently serotonin antagonists. The use of latter drug class 
had generated significant controversy based on reports which have shown an increased 
incidence in abdominal surgeries in patients with pre-exiting IBS (FDA, 2002).
In recent years there has been a shift towards the use of natural products for IBS therapy, 
a frequent trend observed in the treatment of many other disease conditions. Mentha 
piperita oil, an essential oil, also commonly known as peppermint oil, is obtained from the 
leaf of the peppermint oil plant which geographically is found in a myriad of species [e.g. 
Mentha x piperita (Lamiaceae)]. The distinct pungent mint odour of Mentha piperita is
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emitted from the leaf’s secretory glands, as shown in the scanning electron micrograph 
(Figure 4.1). Multi-centre clinical trials have demonstrated significant alleviation of the 
symptoms manifested in IBS through use of Mentha piperita oil. Specifically the ability of 
the oil to alleviate IBS-induced abdominal pain and distension is related to its blockade of 
calcium influx, thereby inhibiting abnormal smooth muscle contraction of the colon (Hills 
and Aaronson, 1991; Beesley et al., 1996).
Furthermore, it is known that overgrowth of enteric bacteria exacerbates the IBS 
symptom-complex by fermentation of ingesta, which leads to elevated production of gas 
(King et al., 1998; Zar et al., 2002). This gas becomes locked in the colon and hence 
extends to increased abdominal pain and cramps. The main component of Mentha 
piperita oil, menthol, has been shown to have profound antimicrobial effects (Pattnaik et 
al., 1997). This pharmacologic action may consequently be manipulated to suppress the 
overgrowth of gas-forming enteric microbes.
Figure 4.1 Scanning electron micrograph of the secretory gland embedded in the 
leaf of the Mentha piperita oil plant.
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In the present study, the design and development of a novel crosslinked calcium- 
aluminium-alginate-pectinate oilisphere complex was undertaken to achieve site-specific 
delivery of Mentha piperita oil conducive to microenvironmental conditions simulating the 
proximal and distal intestine, including the colon. Enteric delivery of this oil is essential for 
three reasons since: (i) contact with the gastric mucosa results in muscle relaxation and 
hence severe oesophageal reflux; (ii) it is hydrolyzed at gastric pH; and (iii) treatment 
should be localized to the afflicted region of the gut, namely the intestine and colon. 
Currently, enteric coating of monolithic dosage forms is the most widely used approach to 
achieve intestinal delivery of Mentha piperita oil (Liu et al., 1997; Kline et al., 2001; 
Micklefield et al., 2003; Weydert et al., 2003). One of the key problems with monolithic 
drug delivery systems is their unpredictable and erratic gastrointestinal transit times, 
which is compounded by variable gastric emptying rates. In IBS patients this rate is 
furthermore largely influenced by the hypothesized “brain-gut axis" relationship 
(Rosemore and Lacy, 2002; Wood, 2002; Nakai and Kumakura, 2003). Decreased 
amplitude and cycle length of migrating motor complexes and increased frequency of 
clustered contractions are observed in IBS patients. Traditionally, this erratic rate of 
gastric emptying has more negatively impacted the responses elicited by enteric-coated 
systems such as tablets and softgels. Erratic emptying behaviour of monolithic dosage 
forms, which do not disintegrate in the stomach, can lead to variable absorption and 
pharmacologic response.
This study attempts to circumvent the above dilemma through the application of novel 
multiple-unit technology that would deliver an appropriate dose of Mentha piperita oil in a 
predictable time to the intestine. In general, it is well-recognized that multiple-unit 
systems have the following advantages: (i) demonstration of predictable gastrointestinal 
transit times since each unit is independent from the contraction/relaxation activities of the 
cardiac and pyloric sphincters of the stomach, (ii) less localized gastrointestinal 
disturbances due to their dispersive capability, and (iii) provide predictable site-specific
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drug targeting based on the application of pH-dependent polymers in their formulation.
In the present study, we postulate that in IBS patients, where treatment of a massive 
membranous surface is required, the rate and site at which the drug is delivered will have 
a significant impact on the success of the therapy. The dispersive capability of swellable 
multiple-unit matrices such as the proposed oilisphere system in this work, will allow for 
more extensive interaction between the intestinal membrane and oil, instead of the 
localized effect achieved with traditional monolithic preparations.
Hence, to achieve the objective of this study, a Plackett-Burman design was adopted. 
The application of this optimization technique would provide an efficient and economical 
method to acquire the necessary information to understand the relationship between the 
controllable (independent) and performance (dependent) variables. The independent 
variables that were evaluated included different levels of alginate and/or pectin exposed 
to varying reaction times in an aqueous calcium chloride, aluminium chloride and/or 
aluminium sulphate crosslinking solution. The responses measured from these reactions 
included matrix resilience, hardness, total fracture energy, erosion and the pH-dependent 
in vitro release characteristics. Final formulation selection was achieved using a 
constrained optimization technique. In addition, Artificial Neural Networks (ANN) was 
employed as an alternative technique to predict the physicochemical and 
physicomechanical properties of the oilispheres using the response data derived from the 
Plackett-Burman design (Sibanda et al., 2004).
4.2 Materials and Methods
A low-viscosity sodium alginate (1%w/v aqueous solution at 21 °C 35cP) was obtained 
from TIC Gums (Maryland, USA). Low methoxyl citrus pectin (degree of esterification 34- 
38%) was donated by Herbstreith and Fox (Neuenburg/Wurttemberg, Germany). 
Anhydrous calcium chloride, aluminium chloride and aluminium sulphate were purchased
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from Sigma (Missouri, USA). Mentha piperita oil (peppermint oil) was obtained from 
Aromatherapy Oils (Johannesburg, South Africa). Spectrophotometric grade 1-octanol 
was purchased from Fluka Chemicals (Buchs, Switzerland).
4.2.1 Formulation of Crosslinked Oilispheres
Oilispheres loaded with Mentha piperita oil were formulated in accordance with a Plackett- 
Burman design having polymer/crosslinking agent concentrations/crosslinking reaction 
times and combinations as depicted in Tables 4.1 and 4.2. The reader is referred to the 
section on “Developing the Experimental Design” for a more comprehensive explanation 
of Tables 4.1 and 4.2.
Table 4.1 Normalized Factor Levels of the Independent Variables for the Plackett 
Burman Design
Variable Factor level-1 1
-  Units
Sodium Alginate 0 1.5 %w/v
Pectin 0 1.5 %w/v
Calcium Chloride 0 4 %w/v
Aluminium Chloride 0 4 %w/v
Aluminium Sulphate 0 4 %w/v
Crosslinkinq Reaction Time 0.5 6 hours
A quantity of sodium alginate and/or pectin (see Tables 4.1 and 4.2) was dissolved in 
deionised water and made up to volume (100mL). To this solution, 50mL of Mentha 
piperita oil was added. Thereafter this multi-component solution was gently homogenized 
for 2 minutes to produce a polymer-oil emulsion (Vortex-Mixer model 947, England). The 
crosslinking solution was prepared by dissolving an appropriate quantity of calcium 
chloride, aluminium chloride and/or aluminium sulphate (see Tables 4.1 and 4.2) in 
deionised water and made up to 1000mL.
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Table 4.2 The Plackett-Burman Matrix
Oilisphere
Formulation
Run
Order
Sodium
Alginate
(%w/v)
Pectin
(%w/v)
Calcium
Chloride
(%w/v)
Aluminium
Chloride
(%w/v)
Aluminium
Sulphate
(%w/v)
Crosslinking 
Reaction Time 
(hours)
F1 7 0 1.5 4 4 0 6
F2 11 1.5 0 4 0 0 0.5
F3 6 1.5 0 0 0 4 6
F4 12 0 1.5 0 0 0 6
F5 14 1.5 1.5 0 4 0 0.5
F6 2 1.5 1.5 0 4 4 0.5
F7 5 0 0 0 0 0 0.5
F8 9 1.5 0 4 4 0 6
F9 3 0 0 4 4 4 0.5
F10 13 0.75 0.75 2 2 2 3.25
F11 4 0.75 0.75 2 2 2 3.25
F12 8 0 0 0 4 4 6
F13 10 1.5 1.5 4 0 4 6
F14 1 0 1.5 4 0 4 0.5
Oilispheres were formed by carefully titrating the above polymer-oil emulsion at 
2mL/minute into the crosslinking solution by means of a 6-channel peristaltic pump 
(Desaga, Heidelberg) fitted with Pharmed® tubing (Cole-Parmer, USA) having a flat-tip 19- 
guage opening. On completion of the titration process, the formed oilispheres were 
agitated in the crosslinking solution for an additional 30 minutes. Thereafter, the 
oilisphere matrices were allowed to cure under dark conditions (±21 °C) for a 
predetermined period of time (see Tables 4.1 and 4.2). Following this curing phase, the 
crosslinking solution was decanted and the oilispheres were washed with 3x500mL 
volumes of deionised water. The oilispheres were then air dried at ±21 °C for 48 hours 
under an extractor.
4.2.2 Physicomechanical Analysis of Crosslinked Oilispheres by Textural Profiling
To determine the resilience behaviour, fracture energy, and matrix hardness of the 
oilispheres, a TA.XT.plus Texture Analyzer (Stable Micro Systems, England) fitted with a 
36mm cylindrical steel probe and 5kg load cell was used. In order to determine the effect 
of hydration of the oilispheres on resilience behaviour, a modified USP 25 rotating paddle
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method was used to hydrate the oilispheres (Pillay and Fassihi, 1998). The oilispheres 
were placed in dissolution vessels containing 900mL phosphate buffer at pH 6.8 
maintained at 37“C. At appropriate time intervals (up to 5 hours) the oilispheres were 
removed from the medium and analyzed in accordance with the textural parameters listed 
in Table 4.3. At each sampling point a quantity of 10 oilispheres were analyzed. The fully 
integrated data acquisition, analysis and display software i.e. Texture Exponent Version
3.2 (Stable Micro Systems, England) was employed. Data acquisition was performed at 
200 points per second.
Table 4.3 Textural Parameters Employed for Total Fracture Energy, Matrix Hardness 
and Resilience Testing______________________________________________________
1 Parameters Total Fracture Energy and Matrix Hardness Settings Resilience Settings
Pre-test speed 1 mm/s 1 mm/s
Test speed 0.2 mm/s 0.2 mm/s
Post test speed 0.2 mm/s 0.2 mm/s
Compression force/distance 60N 50% strain
Trigger type Auto Auto
Trigger force 0.5 g 0.5 g
Load cell 5kg 5kg
Figure 4.2 depicts typical force-distance profiles used to determine the responses 
mentioned in Table 4.3. Figure 4.2a depicts the calculation of matrix resilience, which is 
provided by the ratio of the AUC between anchors 2 and 3, and 1 and 2. An anchor may 
be defined as a perpendicular drop to divide area boundaries.
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Figure 4.2 Typical textural analysis force-time and force-distance profiles of 
crosslinked oilispheres for the determination of: (a) Matrix resilience, (b) Total 
fracture energy, and (c) Matrix hardness. (In all cases it was observed that 
SDs<0.03 were obtained, N=10).
50
Figure 4.2b indicates the calculation of total fracture energy, which is provided by the total 
AUC for a force-distance profile resembling the various phases of matrix fracture (i.e. 
AUC between anchors 1 and 2). The first break in the upward gradient is indicative of a 
primary facture or rupture phase which results in a force reduction. However, on further 
application of force, the residual unfractured material undergoes complete rupture, and 
hence the force peaks at 60N. Figure 4.2c depicts the calculation of matrix hardness 
which is indicated by the steepness of the upward gradient up to the primary fracture 
phase, namely between anchors 1 and 2. In general, a steeper gradient indicates a 
harder matrix.
4.2.3 Developing the Experimental Design
A Plackett-Burman design was developed in this study to screen, evaluate and eventually 
optimize a preliminary formulation from several crosslinked polymeric matrices comprised 
either singly, or in combination, of sodium alginate and/or pectin. The normalized factor 
levels for the independent variables (concentrations of polymer/s, crosslinking agents and 
duration of crosslinking reaction time) are shown in Table 4.1. Unhydrated matrix 
resilience (%), hydrated matrix resilience (%) in buffer media pH 3 and 6.8, matrix 
hardness (N/m), total fracture energy (Joules) and normalized matrix erosion in buffer 
media pH 3 and 6.8 were selected as the dependent variables (responses) in order to 
evaluate the physicochemical properties of the crosslinked matrices. The screening 
matrix was compiled using Microsoft Excel 2002 Macros (Office XP, 2002) namely 
Essential Regression and Experimental Design software Version 2.2 (Pennsylvania, 
USA). The generated matrix required 14 experimental runs including 2 centre points (also 
referred to by oilisphere formulation number, F#), which are depicted in Table 4.2. The 
formulations were produced and tested in a random sequence. The regression model 
(Equation 4.1) encompassing 7 linear terms was as follows:
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Response = b0 + b rfSA ] +bz*[P] +b3*[CC] + b4*[AC] + bs*[AS] + b6*C (Equation 4.1) 
where the terms in parenthesis represent the concentrations of polymers and crosslinking 
agents, b0....b6 are the regression coefficients of the system, SA = sodium alginate, P = 
pectin, CC =calcium chloride, AC = aluminium chloride, AS = aluminium sulphate, and 
CRT = crosslinking reaction time.
4.2.4 Oilisphere Size Analysis
The various oilisphere formulations were subjected to particle size analysis by employing 
a nest of sieves ranging from 5000-150jj.m agitated on a sieve shaker set at medium 
amplitude for 5 minutes (Octagon 200 Test Sieve Shaker, Endecotts Ltd., England). The 
various size fractions were stored separately in glass vials until further use.
4.2.5 Calibration Curve of Mentha piperita Oil in 1-Octanol
Mentha piperita oil was dissolved in 1-octanol to produce a series of standard solutions: 
0.05, 0.1 and 0.15mg/mL. Their absorbance values were determined at the wavelength 
maximum of 230nm. Using this information a calibration curve was constructed (Figure 
4.3). Note that the buffer, polymers and excipients did not show any absorbance readings 
or interference at 230nm.
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Figure 4.3 Calibration curve of Mentha piperita oil in 1-octanol. (In all cases it was 
observed that SDs<0.01 were obtained, N=3).
4.2.6 Determination of Mentha piperita Oil Encapsulation
50mg of oilispheres from each formulation was triturated in a mortar and pestle to release 
the oil. To this pulverized mass, tOOmL 1-octanol was added to separate the oil and 
thereafter transferred to a 500mL beaker. 100mL deionised water was added to the 1- 
octanol phase to dissolve any remaining polymeric fragments in order to ensure complete 
release of the oil. The 1-octanol-water combination was gently magnetically stirred for 1 
hour to facilitate the complete diffusion (partitioning) of oil into the 1-octanol phase. This 
two-phase system was allowed to stand for a further hour. 5mL samples were withdrawn 
from the 1-octanol layer and analyzed by ultraviolet spectroscopy at 230nm for oil content 
(Beckman DU 650 ultraviolet spectrophotometer). All determinations were performed in 
triplicate.
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The encapsulation efficiency was determined by using the following equation:
Oil Encapsulation Efficiency = (AQ/TQ) x  100 (Equation 4.3)
where AQ is the actual quantity of oil encapsulated within the oilisphere and TQ is the 
theoretical quantity of oil expected within the oilispheres. Note that drug content 
determination is inherent in calculating the AO of encapsulated oil.
Among many of the other components, menthol (bioactive agent) was the subject of 
analysis in Mentha piperita oil. A calibration curve of menthol obtained by gas 
chromatography was validated against ultraviolet spectroscopy and reflected no 
significant differences (p<0.05). Ultraviolet spectroscopy was selected due to ease of 
manipulation.
4.2.7In Vitro Release Studies
In vitro release studies (Caleva Dissolution Apparatus, model 7ST) were performed on 
optimized formulations using a modified USP 25 rotating paddle method in a two-phase 
media system maintained at 37"C (Pillay and Fassihi, 1998). The lower phase consisted 
of 350mL USP-recommended buffers of either pH 1.5, 4 or 6.8, while the upper phase 
consisted of 200mL 1-octanol. The buffers were also chosen to complement the 
Biopharmaceutics Classification System. The 1-octanol layer served as a sink for Mentha 
piperita oil as its diffusion occurred from the lower to upper phase. Dissolution studies 
were conducted on a quantity of oilispheres equivalent to 50mg of Mentha piperita oil. 
The oilisphere samples were introduced into the buffer phase below a ring-mesh device 
(Pillay and Fassihi, 1998) prior to the addition of 1 -octanol (Figure 4.4).
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Figure 4.4 Schematic of the two-phase release medium within a dissolution vessel.
The rotating paddles were operated at 50rpm. 5mL samples of 1-octanol were withdrawn 
at appropriate time intervals over a period of 12 hours and analyzed by ultraviolet 
spectroscopy at 230nm. An equivalent volume of oil-free 1-octanol was replaced into 
each vessel sampled. In cases where dilution of samples was required, an appropriate 
correction factor was employed.
4.2.8 Determination of Matrix Gravimetric Changes
50mg of oilispheres were accurately weighed to four decimals and placed into dissolution 
vessels containing 500mL buffer of pH 3 and 6.8 maintained at 37^3. The oilispheres 
were agitated at 50rpm using the above-described modified USP 25 rotating paddle 
apparatus. The entire quantity of oilispheres remaining in the buffer medium was
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removed at appropriate time intervals (up to 8 hours). The oilispheres were placed on 
pre-weighed petri-dishes and dried to constant weight at 21 °C under an extractor. The 
mass of the dried residue was determined and expressed as the normalized matrix weight 
change computed from their initial mass deviation. All determinations were performed in 
triplicate.
4.2.9 Microwell Plate Coating of Oilispheres
A novel fusion coating procedure was developed to attach oil-free crosslinked and 
uncrosslinked peripheral layers around the oilispheres. Individual oilispheres were 
introduced into microwells having a 200pL capacity. In the first case, a 2%w/v binary 
coating solution of a 1:1 combination of alginate and pectin was prepared (viscosity of 
920cP at 21 °C), of which 50p.L was added to each microwell containing an oilisphere. 
The microwell plate was thereafter agitated on a vortex (Genie Vortex-2, Scientific 
Industries, USA) for 30 seconds in order to ensure that the oilispheres were completely 
coated with the binary mixture. This procedure provided an uncrosslinked peripheral layer 
around the oilispheres. In the second case of attaching crosslinked layers around the 
oilispheres, the same procedure was applied, except for the addition of 50|i,L of the 
crosslinking agent comprised of an aqueous solution of 4%w/v each of aluminium 
sulphate, aluminium chloride and calcium chloride. After addition of the crosslinking 
agent the microwell plate was agitated on the vortex for 30 seconds to allow for fusion to 
occur. The oilispheres (uncrosslinked and crosslinked layers) were then dried at ±21 °C 
for 48 hours under an extractor.
4.2.10 Microbiological Assay of Mentha piperita Oil
Minimum inhibitory concentrations (MIC) were determined for Mentha piperita oil against 
common gas-forming enteric flora: Proteus vulgaris, Serratia odorifera, Enterobacter, 
Salmonella typhi, Salmonella enteriditis, Citrobacter, Enterococcus faecalis, Klebsiella
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pneumonia, Candida albicans, Staphylococcus aureus, Escherichia coli and Yersinia 
enterolitica.
4.2.11 Data Analysis
The Plackett-Burman screening design was built and analysed using the Microsoft Excel 
2002 Add-in, Essential Regression and Experimental Design software Version 2.2 
(Pennsylvania, USA). Textural analysis of data was performed on Texture Exponent 
Version 3.2 (Stable Micro Systems, England). Statistical significance was analyzed by a 
paired two-tailed student t-test at a 95% confidence interval (p<0.05) (Microsoft Excel 
2002). All least squares analyses performed to determine the mechanisms of Mentha 
piperita oil release was analyzed on WinNonlin Professional Edition Version 3.3 
(Pharsight, USA) using the Gaussian-Newton (Levenberg-Hartely approach). Prediction 
of data by Artificial Neural Networks (ANN) was conducted on NeuroSolutions Version 
4.22 (NeuroDimension Inc., USA).
4.3 Results and Discussion
4.3.1 Sieve Analysis
Typically unimodal and bimodal size distributions were observed, showing the 2mm 
oilispheres as having the highest frequency (Figure 4.5). This size fraction was chosen 
for all investigations in this study. Bimodal distribution was attributed to deaggregation of 
the homogenized droplets into smaller and larger populations during the crosslinking 
process as a result of a high interfacial tension that would be expected between the 
surface of the aqueous crosslinking solution and the oily residue around the periphery of 
the droplets.
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Figure 4.5 Size distributions of the crosslinked oilisphere matrices indicating 
unimodal and bimodal profiles. (In all cases it was observed that SDs<0.06 were 
obtained, N=3).
This oily residue may have prevented rapid interaction between the polymer and 
crosslinking solution, hence leading to heterogeneous separation of a single droplet.
4.3.2 Drug Encapsulation
Encapsulation of Mentha piperita oil within the crosslinked matrices ranged between 6- 
35mg per 100mg oilispheres (Figure 4.6). This was attributed to the differences in the 
degree of crosslinking and hence the variation in the encapsulation efficiency. 
Oilispheres with a low crosslink density demonstrated low oil encapsulation. A 
relationship between specific textural analysis parameters and the degree of crosslinking 
have already been established (Pillay and Danckwerts, 2002).
58
35 -
30 -
0 3 6 9 12 15
Formulation Number
Figure 4.6 Encapsulation efficiency of Mentha piperita oil within the crosslinked 
matrices. (In all cases it was observed that SDs<0.1 were obtained, N=3).
4.3.3 Gravimetric Transitions of the Crosslinked Matrix
It should be noted that matrix erosion can have an impact on the release of drugs and 
other bioactive substances from their delivery systems. In this study, essentially two 
types of weight change behaviour were noted upon hydration of the oilispheres in either 
phosphate buffer pH 3 or 6.8 (Figure 4.7a,b).
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Figure 4.7 Erosional behaviour of the crosslinked oilispheres depicting (a) ion 
sequestration, and (b) 3 phases of ion loss, sequestration and matrix erosion. (In 
all cases it was observed that SDs<0.1 were obtained, N=3).
In the first instance there was an increase in the oilisphere weight during the first 2 hours 
of hydration. This was attributed to the sequestration of phosphate ions from the release 
medium, which was thereafter followed by a plateau (Figure 4.7a). The ionic threshold 
concentration for sequestration has previously been mathematically described by Pillay 
and Fassihi (1999a). Curve-fitting of these data (Figure 4.7a) indicated that such 
behaviour followed an exponential rise to a maximum (R2>0.99), as described by the 
following equation:
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(Equation 4.4)M t = M 0( I - e " w )
where Mt = mass of matrix at time t, M0 = original mass of matrix, and kseq = exponential 
rate constant of ion sequestration.
In the second instance (Figure 4.7b), three phases were observed. Initially there was a 
rapid decline in the matrix weight (Phase I), followed by ion sequestration (Phase II) and 
then rapid erosion to a plateau (Phase III), indicating complete matrix dissolution. Curve­
fitting of this data indicated that these phases could be described by the following 
equations, each producing an R2>0.99:
- Phase I: Simple exponential loss of soluble ions from the surface of the oilisphere:
M t =  M 0e ksolt (Equation 4.5)
where kso,= first-order solubility constant rate of the ions.
- Phase II: As the oilisphere starts to swell, it exponentially sequesters these ions back 
into the matrix:
M  t = M  Qe (Equation 4.6)
where kseq = exponential rate constant of ion sequestration.
- Phase III: Higuchi-type erosion of the matrix represented by the cube root of time 
equation:
M ,  =  k en \J t (Equation 4.7)
where kero = matrix erosion rate constant.
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4.3.4 Physicomechanical Behaviour of Crosslinked Polymeric Oilispheres
Textural profiling revealed a decrease in the fracture energy, and increase in matrix 
hardness and resilience, in relation to the statistical combinations and concentrations of 
the crosslinkers. In general, aluminium chloride and sulphate provided a matrix 
reinforcing function while calcium chloride principally crosslinked the polymeric system, as 
determined from preformulation work. Through these preliminary studies the specific 
crosslinkers were selected as the ionotropic agents in this study.
The crosslinked oilispheres were spherically shaped with a uniform diameter of 
approximately 2mm. In addition, their surfaces appeared homogeneous and dense. 
Macros run on Texture Exponent Version 3.2 were able to calculate various parameters 
namely matrix resilience (unhydrated and hydrated), matrix hardness and total fracture 
energy. The experimental values for these parameters may be found in Table 4.4, and 
this clearly outlines that all oilisphere formulations had very low fracture energy values i.e. 
the matrix was very fragile and hence ruptured upon application of a force of 60N.
4.3.5 Stepwise Regression Analysis
Using Essential Regression and Experimental Design Software, repeated forward and 
backward stepwise regression was employed to generate the equations for each 
response parameter which was fitted to a linear polynomial model (Equation 4.1). The 
predicted and experimental values for each response parameter shown in Table 4.4 is 
correlated by the Cook’s Distance (CD) which essentially measures the overall influence 
of each observation on the regression coefficients, including the intercept. The CD values 
presented in Table 4.4 are rounded-off to two decimal places for convenience. The 
complete values up to six decimal places were used for correlation purposes. Figure 4.8 
and 4.9 depict a close correlation between the experimental and predicted data obtained 
for each of the response parameters in relation to the formulation outlined in the Plackett- 
Burman design (p<0.05). Based on the extreme intra-response variability (Table 4.4) it is
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evident that crosslinking significantly changes the matrix structural-dynamics.
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Figure 4.8 Correlation between experimental data and values predicted by the 
response models for: (a) hydrated matrix resilience in buffer medium pH 3, (b) 
hydrated matrix resilience in buffer medium pH 6.8, (c) matrix hardness, and (d) 
total fracture energy. Note that the unhydrated matrix resilience (not shown) was 
overall =20% higher than that of the hydrated matrices. (In all cases for the 
experimental studies it was observed that SDs<0.02 were obtained, N=10).
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Table 4.4 Correlation between Predicted and Experimental Responses Generated from the Plackett-Burman Design
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C D E x p P re d C D E x p P re d C D
F1 8 .4 8 2 7 .9 2 0 .3 2 3 .9 8 1 1 .1 8 0 .0 8 3 .2 2 5 .2 8 0 .1 0 6 3 4 1 .8 2 -6 7 4 .5 5 0 .2 2 0 .0 1 0 0 .0 0 7 0 .0 4 0 .3 0 1 0 .141 0 .0 3 0 .5 6 1 -1 .13 1 0 .0 3
F 2 3 .0 8 3 8.11 0 .4 6 4 .2 7 1 9 .3 5 0 .3 6 0 .6 3 4 .9 6 0 .4 6 4 1 4 2 .1 0 -3 2 9 .7 5 0 .0 9 0 .0 1 4 0 .0 1 1 0 .0 2 0 .0 0 3 -0 .0 0 8 0 .0 6 -0 .1 8 6 -0 .2 0 8 0.01
F3 7 .9 7 3 8 .1 1 0 .3 2 2 3 .9 3 3 5 .1 0 0 .2 0 4 .2 5 4.21 2 .8 7 5 4 3 3 .8 4 6 1 4 2 .5 0 0 .0 2 0 .0 1 2 0 .011 0 .1 2 2 .3 4 1 2 .0 3 1 0 .0 2 4 .2 6 4 1 .9 3 2 0 .0 2
F 4 0 2 7 .9 2 0 .1 3 0 1 0 .0 8 0 .1 6 0 0 .9 7 0 .0 8 0 -1 5 0 4 .7 0 0.01 0 .0 0 9 0 .0 0 7 0 .0 2 0 0 .3 0 8 0 .0 3 0 0 .3 8 4 0 .0 3
F5 1 02 .01 7 7 .6 8 0 .1 4 4 .4 7 2 .2 7 9 0 .0 0 1 .5 6 3.91 0 .0 2 1 5 5 7 1 .7 6 3 0 5 3 0 .6 0 1 .0 3 0 .0 1 4 0 .0 1 7 0 .0 0 1 .7 2 4 1 .5 0 8 0 .0 4 -0 .0 3 5 -0 .7 6 8 0 .01
F 6 7 1 .0 2 7 7 .6 8 0 .3 2 4 .2 3 1 3 .0 7 0 .1 2 3 .7 5 2 .9 2 0 .1 3 5 4 4 1 1 .6 3 7 8 4 6 .4 0 0 .1 0 0 .0 1 6 0 .0 1 7 0 .0 0 0 .0 1 2 0 .0 9 9 0 .0 2 -0 .7 2 6 -0 .2 9 9 0 .0 4
F7 0 -1 1 .6 5 0 .2 5 0 0 .2 5 0 -0 .7 3 0 .01 0 -4 8 5 9 .6 0 0.01 0 .0 0 3 0 .0 0 1 0 .0 2 0 0 .0 0 7 0 .0 5 0 0 .3 5 7 0 .0 2
F8 4 7 .6 4 3 8.11 0 .0 3 2 3 .2 3 12.41 0 .0 3 1 3 .9 3 9.51 0 .01 1 5 8 2 .4 2 -3 4 3 .2 0 0 .0 4 0 .0 0 9 0 .0 1 1 0 .2 2 -0 .2 5 2 0.01 -0 .84 1 -0 .05 1 0 .0 3
F 9 0 -1 1 .6 5 0 .0 6 0 25.41 0 .0 6 0 2 .5 8 0 .4 8 0 3 2 8 6 .4 0 0 .0 4 0 .0 0 3 0 .001 0 .0 2 0 .5 3 1 -0 .00 1 0 .01 0 -0 .6 9 0 0 .0 3
F 1 0 5 3 .7 2 3 3 .0 2 0 .0 4 3 4 .6 4 0.01 8 .0 4 3 .4 9 0 .1 6 2 6 4 1 .7 4 7 4 6 1 0 .0 5 0 .0 1 1 0 .0 0 9 0 .0 0 0 -0 .0 2 2 0 .0 2 -0 .9 1 6 -0 .0 0 2 0 .0 2
F11 5 3 .7 2 3 3 .0 2 0 .0 2 3 4 .6 4 0 .5 2 2 0 .01 8 .0 4 3 .4 9 0 .01 2 6 4 1 .7 4 746 1 0 .0 2 0 .0 1 1 0 .0 0 9 0 .0 0 -0 .4 1 2 0 .0 2 -0 .9 1 6 -0 .0 0 2 0 .0 8
F 1 2 0 -1 1 .6 5 0 .01 0 14.71 0 .0 3 0 2 .8 3 0 .01 0 2 4 4 2 .8 0 0 .0 2 0 .0 0 2 0 .001 0 .0 3 0 .3 3 0 0 .0 0 1 0 .0 5 0 0 .9 8 1 0 .0 2
F 1 3 9 4 .9 5 7 7 .6 8 0 .4 9 6 7 .7 6 14.71 0 .3 7 2 .5 1 5 .6 7 0 .1 9 7 8 6 4 .9 8 10341 0 .0 3 0 .0 1 8 0 .0 1 7 0 .0 9 0 .481 0 .0 2 -0 .6 6 5 0 .2 8 8 0 .0 4
F 14 1 9 .6 5 2 7 .9 2 0 .01 4 .7 7 4 .4 3 9 0 .2 0 2 .8 9 -0 .2 6 0 .2 4 3 8 2 2 .4 8 6 6 5 4 .7 0 0 .0 7 0 .0 1 1 0 .0 0 7 0 .0 3 0 .3 3 0 -0 .4 7 8 0 .01 -0 .5 6 3 -0 .8 1 8 0 .0 3
' Experimental value for response 
2Predicted value for response 
3Cook’s Distance
4 Values are normalized such that the reference point is zero
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Figure 4.9 Correlation between experimental data and values predicted by the 
response model for gravimetric transitions in buffer media of pH 3 and pH 6.8. (In 
all cases for the experimental studies SDs<0.05 were obtained, N=10).
4.3.6 Constrained Optimization
A constrained optimization technique was employed to generate the optimum setting for 
the oilisphere formulation using maximization of the fracture energy as the major 
optimization objective. Among different techniques that were available for solving 
constrained optimization problems, the most popular appeared to be the Lagrangian and 
Simplex methods. In this study, optimization was undertaken using the Lagrangian 
method introduced by Fonner and co-workers (1970), which could be achieved by 
employing the Microsoft Excel 2002 Solver function (Lin et al., 2001; Pillay and 
Danckwerts, 2002).
Maximization of the total fracture energy was selected as the most favourable parameter 
(response) for formulation optimization over two other popular parameters, namely 
unhydrated matrix resilience and matrix hardness. Tables 4.5 and 4.6 provide a detailed 
analysis of the mathematical fit of data for each response function and their levels of 
significance. This analysis is required for the selection of the objective function to be
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applied in the constrained optimization.
Regression on the unhydrated matrix resilience and matrix hardness resulted in suitable 
R2 values, while significantly high CV values were obtained. On the other hand, the total 
fracture energy provided a compatible set of statistical values i.e. high R2 and low CV.
The selection criteria applied to these objectives critically depend on the chemical 
properties of the crosslinked matrix, as outlined in a recent paper by Pillay and 
Danckwerts (2002) which showed that the degree of crosslinking is a critical parameter 
that regulates various properties of the oilispheres such as the dynamics of matrix 
erosion, swelling and drug release. In the present study, experimental results indicate 
that optimum crosslinking is associated with maximum fracture energy (Tables 4.4, 4.5 
and 4.6).
The following constraint boundaries (%w/v or hours) for the independent variables were 
imposed in a similar manner as outlined in the work of Pillay and Danckwerts (2002) in 
terms of polymer manipulation, total fracture energy data, and generation of ideal drug 
release rates:
(i) 1 < [sodium alginate] < 2
(ii) 1 < [pectin] < 2
(iii) 1 < [calcium chloride] < 6
(iv) 1 < [aluminium chloride] < 6
(v) 1 < [aluminium sulphate] < 6
(vi) 0.5 < crosslinking reaction time (hours) < 6
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Table 4.5 Complete Fit of Functions for Response Parameters and their Respective 
Regression Diagnostics
Durbin-
Responses
Measured Plackett-Burman Equations R2
Watson 
d Index CV (% )
(% )
U nhyd ra ted b0+b, *[SA]+b2*[P]+b3 *[CC]+b4*[AC]+bs’[AS]+b6*CRT 0.74 1.45 77.26
M atrix
R esilience
(Equation 4.8)
(%)
H ydrated b0+b, *[SA]+b2 *[P]+b3 *[CC]+b4 *[AC]+bs *[AS]+b6 *CRT
M atrix
R es ilience :
(Equation 4.9) 0.63 1.60 112.42
pH 3 (%)
H ydrated b0+b, *[SA]+b2 *[P]+b3 *[CC]+b4 *[AC]+b5*[AS]+b6 *CRT
M atrix  
R es ilience : 
pH 6.8  (%)
(Equation 4.10) 0.41 1.94 121.74
M atrix b0+b, *[SA]+b2 *[P]+b3 *[CC]+b4 *[AC]+b5’[AS]+b6' CRT
H ardness (Equation 4.11) 0.74 2.20 131.60
(N /m )
F racture b0+b, *[SA]+b2 YP]+b3 *[CC]+b4 *[AC]+bs *[AS]+b6 *CR T
E nergy (J) (Equation 4.12) 0.88 1.75 33.21
G rav im e tric b0+b, *[SA]+b2 YP]+b3 *[CC]+b4 *[AC]+bs*[AS]+b6*CRT
T rans ition s : (Equation 4.13) 0.42 1.21 79211 .24
pH 3
G rav im e tric b0+b, YSA]+b2 *[P]+b3 *[CC]+b4 *[AC]+b5*[AS]+b6 ‘CR T
T rans ition s : (Equation 4.14) 0.37 1.75 78918 .52
pH 6.8
Table 4.6 Level of Significance of Regression Coefficients in Response Functions
at a 95% Confidence Interval (p<0.05)
Independent 1UMR 2HMR: 4MH 
Coefficient va£ ables (%) pH3 (%) p " 6/ 8 (N/m)
( '°l
5TFE (J) 6GT: pH 3
7GT: 
pH 6.8
bO 0.376  0 .314  0 .780  0 .616 0.804 0.832 0.804
b 1 [SA ] 0 .0 117 8  0.07611 0 .206  0 .05355 0.00061 0.431 0.722
b2 [P] 0 .0 312 3  0 .574  0.751 0 .05837 0.01127 0.546 0.373
b3 [C C ] 0 .9 37  0 .253  0 .385  0 .173 0.08114 0.435 0.324
b4 [A C ] 0 .280  0 .295  0 .434  0 .140 0.598 0.423 0.453
b5 [AS ] 0 .725  0 .296  0 .698  0 .238 0.367 0.654 0.584
b6 C R T  0 .690  0.121 0 .339  0 .139 0.620 0.323 0.357
Unhydrated matrix resilience 
2Hydrated matrix resilience in pH 3 
3Hydrated matrix resilience in pH 6.8 
4Matrix hardness 
sTotai fracture energy 
6Gravimetric transition in pH 3 
7Gravimetric transition in pH 6.8
67
Polymer concentrations for sodium alginate and pectin beyond 2%w/v were not feasible 
as accurate titration was significantly inhibited by their excessively high viscosity. The 
upper limits for the crosslinking agents were based on their ability to produce optimal 
crosslinking. The lower limits for both polymers and crosslinking agents were the 
necessary minima for the production of spherical oilispheres. The crosslinking reaction 
times were based on minimization of the loss of Mentha piperita oil into the crosslinking 
solution.
Table 4.7 reflects the results based on the above constraint optimization technique for 
development of the ideal oilisphere formulation. In order to validate the accuracy of the 
predicted formulation parameters, the model predicted values were compared against the 
experimental values generated from fracture energy analysis on the oilispheres. Excellent 
correlation was obtained (Table 4.7).
Table 4.7 Composition of the Optimized Oilisphere Formulation Obtained By the 
Constrained Technique and Comparison of Experimental and Predicted Total 
Fracture Energy Values_____________________________________________________
Formulation Components Concentrations (%w/v) and Reaction Time (hours)
Sodium Alginate 1.5
Pectin 1.5
Calcium Chloride 4
Aluminium Chloride 4
Aluminium Sulphate 4
Crosslinking Reaction Time 3
Formulation Analysis Total Fracture Energy (Joules)
Experimental 0.011510.003 (N=10)
Predicted 0.0107
A three-dimensional trajectory residual plot for the total fracture energy corresponding to 
the 14 formulations (Figure 4.10) showed data homogeneity, without any specific trend 
and hence no model transformation was required. Frequently simple X-Y plots obstruct 
internal residual patterns.
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Figure 4.10 Three-dimensional trajectory plot of the residuals for the total matrix 
fracture energy.
Figure 4.11 illustrates a typical surface response plot for the effects of crosslinking 
reaction time and crosslinker concentrations on the total fracture energy. All other 
combinations of the surface plots were analyzed but are not shown due to the statistical 
emphasis placed on the total fracture energy. It was observed that as the concentration 
of calcium chloride was increased, the total fracture energy also significantly increased. 
The same effect was also observed for aluminium chloride and sulphate. Flowever, in the 
case of the crosslinking reaction time, a maximum of 3 hours was required with no 
significant effects thereafter. In terms of the polymer concentrations, an increase yielded 
higher total fracture energy values. It is imperative to account for the fact that the total 
fracture energy is a function of the elasticity or plasticity of a material.
In this work, a Generalized Feed Forward (GFF) neural model was selected to predict the 
total matrix fracture energy values using data generated in the Plackett-Burman statistical
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matrix format (Tables 4.2). Essentially, a GFF is a generalization of a Multilayer 
Perceptron (MLP) such that network connections can jump over one or more hidden 
layers. In theory, a MLP can solve any problem that a GFF network can solve. In 
practice, however, GFF networks often solve the problem much more efficiently (Nelson 
and Illingworth, 1992; Principe et al., 1998).
Figure 4.11 Typical surface plot indicating the influence of increasing the 
crosslinker concentration and crosslinking reaction time (CRT) on the total matrix 
fracture energy. Note the same effect was observed for the other crosslinkers. An 
increase in the polymer concentration also increased the total fracture energy in a 
similar manner.
4.3.7 Comparison of Predicted Response Values for Total Matrix Fracture Energy 
Using Artificial Neural Networks and the Piackett-Burman Regression Analysis
To analyze the data, the neural model employed one hidden layer. For the hidden and 
output layers a genetic algorithm with the SigmoidAxon transfer function and the 
ConjugateGradient learning rule was respectively employed. A maximum of 5000 epochs 
were run 50 times to ensure optimal training of data. Figure 4.12 illustrates the gradual 
levelling of the average mean square error (MSE) with standard deviation boundaries for
70
50 runs. Table 8 reflects the average of the MSE values for all training runs, the best 
network run out of 5000 epochs run 50 times and also provides and indication of how well 
the data has been trained. Overall, this data shows that the training model employed was 
highly efficient. The parameters depicted in Table 4.8 are standard statistical indicators 
used in neural networks to describe the accuracy of the model prediction. These 
indicators are used in the selection of the optimal neural model (e.g. MLP versus GFF).
Figure 4.12 Average MSE with standard deviation boundaries for 5000 epochs run 
50 times.
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Table 4.8 Neural Network Indicators Characterizing the Efficiency of the Training
2 Averages of the Minimum Training Errors TrainingMinimum
Training Standard 
Deviation
Average of Minimum MSEs 0.039647207 0.011162308
Average of Final MSEs 0.039647207 0.011162308
Optimal Network Run Obtained from Data 
Training For Total Matrix Fracture Energy
Run # 17
Epoch # 5000
Minimum MSE 0.019716412
Final MSE 0.019716412
Performance of Neural Network by Testing of 
Training Data For Total Matrix Fracture Energy
MSE 1.57731E-05
Normalized MSE 0.419817367
Mean Absolute Error 0.002779493
Minimum Absolute Error 5.16934E-06
Maximum Absolute Error 0.009048942
Correlation Coefficient 0.76189204
Using all 14 formulations (Table 4.9), the total matrix fracture energy was predicted by 
both Plackett-Burman design and neural networks. The mean differences between the 
experimental and predicted total fracture energy and neural network values when 
compared using a two-tailed paired student t-test, showed no significant differences 
(p=0.265). Hence, as a predictive tool, it appears that artificial neural networks may be a 
better choice in terms ease of operation, time-saving, and no critical need to be able to 
mathematically factor out solutions. On the other hand, the Plackett-Burman approach 
like all other traditional Experimental Designs, require the researcher to possess strong 
mathematical modelling skills and is a time-consuming technique when modelling and 
optimization has to be conducted.
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Table 4.9 Comparisons of Experimental and Predicted Total Matrix Fracture Energy 
Values Derived for 14 Formulations Using the Plackett-Burman Matrix and Artificial
Neural Networks__________________________________________________________
_______________Total Matrix Fracture Energy (Joules)_____________
Predicted
Oilisphere Exoerimental by Predicted by
Formulation p Plackett- Neural Networks
Burman
F1 0.010 0.007 0.011
F2 0.014 0.011 0.013
F3 0.012 0.011 0.012
F4 0.009 0.007 4.274x10
F5 0.014 0.017 0.014
F6 0.016 0.017 0.016
F7 0.003 0.001 0.001
F8 0.009 0.011 0.006
F9 0.003 0.001 0.006
F10 0.011 0.009 0.006
F11 0.011 0.009 0.007
F12 0.002 0.001 0.009
F13 0.018 0.017 0.012
F14 0.011 0.007 0.013
Traditional statistical analysis such as the Plackett-Burman design does not provide “ideal 
values” but rather a list of solutions ranging from the most to least significant. 
Alternatively, a neural network provides a solution that zooms in only on the target values.
4.3.8 Optimization of the Oil Release as per Constrained Optimization Solution in 
Conjunction with a Fusion Coating Technique
Based on the fact that Mentha piperita oil is unstable in the acidic environment, the 
delivery system had to possess an ability to protect the oil from the harsh gastric 
environment, while modulate its delivery in the proximal and distal intestine.
Through application of the Plackett-Burman design and by constrained optimization of the 
total matrix fracture energy, a pH-dependent zero-order releasing oilisphere system was 
developed (Figure 4.13). Figure 4.13a,c,e indicate the release of the oil in different buffer 
media, while Figure 4.13b,d,f reflect a composite profile in sequentially changing buffer
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media.
Residual amounts of oil was still detected in buffer medium pH 1.5 (Figure 4.13a,b). In an 
attempt to resolve this, a coat of alginate and pectin was applied to individual oilispheres 
using a microwell plate. In the first approach, simple coating of the oilispheres with a 
solution of native alginate and pectin in a microwell plate followed by drying resulted in a 
decrease in the drug release over the physiological pH range of 1.5-6.8; however oil was 
still detected in the acid media (Figure 4.13c,d). In the second approach the applied coat 
of alginate and pectin was crosslinked by calcium chloride, aluminium chloride and 
aluminium sulphate. The additional crosslinking resulted in the production of a 2-4 hour 
lag-time in release of the oil in the acidic environment (Figure 4.13e,f), which from a 
biopharmaceutical perspective is adequate time for gastric emptying of multiple-units to 
occur (Wilding et al., 2001). This formulation could be regarded as ideal for the purposes 
of site-specific delivery of Mentha piperita oil.
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Figure 4.13 Release profiles of Mentha piperita oil from oilispheres in simulated 
gastric and intestinal fluid (pH 1.5, 4, 6.8): (a,b) Without fused coat, (c,d) With 
uncrosslinked fused coat, and (e,f) With crosslinked fused coat. (In all cases it was 
observed that SDs<0.09 were obtained, N=3).
4.3.9 Kinetic Modelling of Release Data from the Optimal Formulation Composed of 
the Crosslinked Fused Coat
Various kinetic models were employed to identify the mechanism involved in the release 
of the oil from the optimized oilispheres using release data derived from the composite 
profile (Figure 4.13f), which essentially displayed site-specific biphasic release kinetics, 
characterized by a 4-hour lag phase followed by zero-order release. We will not describe 
the equations below in detail as this information can be found elsewhere (Pillay and 
Fassihi, 1999a). Kinetic modelling was applied using a modified form of the Power Law 
equation:
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M/M*=k1(t-tL)n (Equation 4.15)
where k! is the Fickian kinetic constant, tL represents the delay or lag time (4 hours) prior
to release of the oil and n is a release exponent.
Alternatively, Fickian diffusion and matrix relaxation/dissolution were analyzed through the 
use of an expanded version of Equation 4.15:
M/M„=k1(t-tL)n+k2(t-tL)2n (Equation 4.16)
where k2 is the relaxation/dissolution rate constant (i.e. anomalous transport).
Hopfenberg’s modified model (Pillay and Fassihi, 1999a) was either applicable to a slab, 
cylinder or sphere showing heterogeneous erosion. In order to account for the lag time a 
modification was made:
M/M~=1-[1- K1 (t- tL)T (Equation 4.17)
where K, is the overall erosion rate constant, and n=1 for a slab, n=2 for a cylinder, and 
n=3 for a sphere. Table 4.10 indicates the results from kinetic modelling.
Table 4.10 Release Kinetics Obtained from Various Models
Model
Mt/M.= ki (K,) k2 n rAIC 2SC 3CN
k i( t - t jn 0.74 - 0.59 -48.49 -50.29 20.44
k ,f+ k 2f n 0.13 0.02 0.56 -48.02 -50.72 21.26
i - n -  w -  t o r 0.04 - 3 -42.25 -43.16 2377
'Akaike information Criteria 
2Schwartz Criteria 
3 Condition Number
From Table 4.10 it may appear at first glance that all three models may suitably fit the 
dissolution data based on the AIC and SC values. However, upon consideration of the 
CN value, it is evident that the Hopfenberg model is highly unstable (high value). The
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Power Law and Power Law variant appear to suitably fit the data and statistically satisfy 
all parameters. Based on the n-values and the low k2 value in these equations, it is clear 
that diffusion is the predominant mechanism. This is also understandable from the fact 
that the oilisphere consists of a crosslinked membrane encapsulating the oil and acting as 
a barrier to diffusion.
4.3.10 Antimicrobial Activity of Mentha piperita Oil
Despite evidence of strong antimicrobial activity (Pattnaik et al., 1997; Iscan et al., 2002), 
Mentha piperita oil has not been specifically investigated for an effect on small intestinal 
bacterial overgrowth. These researchers have shown in a case report that marked 
improvement in IBS-like symptoms and significant reductions in hydrogen production after 
treatment with enteric-coated Mentha piperita oil may be achieved.
In our antimicrobial studies, it was found that the minimum inhibition concentrations (MIC) 
ranged between 8-32mg/mL of Mentha piperita oil with E. coli displaying the greatest 
resistance (Table 4.11). The microwell plate indicates the red stain (shown as black due 
to photographic reproduction) which reflects the binding of the oil to microbial DNA (Figure 
4.14).
Table 4.11 Minimum Inhibition Concentrations (MIC) of Mentha piperita Oil on a 
Host of Micro-Organisms Commonly Found in the Gastrointestinal Tract__________
Number Allocated to 
Organism Organism MIC (mg/mL)
1 Proteus vulgaris 16
2 Serratia odorifera 8
3 Enterobacter 8
4 Salmonella typhi 8
5 Salmonella enteridltis 8
6 Citrobacter 8
7 Enterococcus faecalis 8
8 Klebsiella pneumonia 16
9 Candida albicans 8
10 Staphylococcus aureus 16
11 Escherichia coli 32
12 Yersinia enterolitica 8
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Concentration 
of Mentha 
piperita 
(mg/ml)
p-iodotetrazolium violet-binding to DNA
Figure 4.14 Different degrees of binding of p-iodotetrazolium violet dye to DNA of a 
host of micro-organisms indicated by different stain darkening in each microwell.
4.4 Concluding Remarks
This work has demonstrated a statistically robust approach for the formulation of novel 
crosslinked oilispheres containing Mentha piperita oil for potentially treating IBS. The 
physicochemical and textural dynamics of the highly complex matrix formed between 
sodium alginate and pectin crosslinked with calcium chloride, aluminium chloride and 
aluminium sulphate was significantly influenced by these independent variables. Among 
the dependent variables (responses) selected for formulation optimization, the total matrix 
fracture energy provided a statistically feasible optimization objective.
Overall, the Plackett-Burman approach and neural model did not show any significant 
differences in predicting the physicochemical and physicomechanical properties of the 
polymeric matrix. However, in terms of modelling efficiency, it appears that Artificial 
Neural Networks may be a superior alternative. In view of these findings, this study will 
be of benefit, to pharmaceutical scientists particularly involved in the application of 
experimental designs and computer-aided simulations for the development of natural 
phytochemical delivery formulations.
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Chapter Five
Application of a High Resolution Box-Behnken Design for the Selection of a 
Crosslinked Zinc-Alginate-Pectinate Framework
5.1 Introduction
In Chapter 4, we have strongly established that Experimental Design is an integral 
scientific approach for the rational development of novel polymeric complexes via 
innovative statistical and mathematical manipulation of crosslinking reactions. The 
present Chapter extends this application by elevating Experimental Design to the higher 
resolution Box-Behnken matrix to develop a primary crosslinked polymeric backbone that 
will be employed as a framework in subsequent studies for release-rate modulation of 
model drug substances. This primary framework comprises a novel crosslinked zinc- 
alginate-pectinate complex.
Today's ideas on drug administration have far reached the scope of simple tablet 
manufacturing, and in order to stay ahead, many pharmaceutical companies spend 
millions of dollars in research and development, in an attempt to outwit their competitors 
by investing in new technologies. One such challenging field is in the design of novel 
multiparticulate technology, whereby release rate can be adjusted and controlled in a 
predictable manner.
In this study, the crosslinking potential of pectin and alginate will be manipulated. Pectins 
are anionic soluble non-starch polysaccharides extracted from plant cell walls. They are 
predominantly linear polymers of mainly alpha (1-4) linked D- galactouronic acid 
monomers interrupted by 1,2-linked L-Rhamnose monomers (Figure 5.1).
Alginic acid, on the other hand is a high molecular weight polysaccharide derived from
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kelp. Essentially, it is a linear copolymer composed of 1,4-linked [3-D-mannuronic acid 
and alpha-L-guluronic acid units (Figure 5.2) (Pronova Biopolymers, 1994; Pillay and 
Fassihi, 1999a,b).
Figure 5.1 Monomeric structure of alginate (M = mannuronic acid units, G = 
guluronic acid units) (source: http://www.lsbu.ac.uk/water/hyalg.html).
Figure 5.2 Monomeric structure of pectin (source: http://www.cpkelco.com).
Divalent and trivalent ions, in particular, crosslink with these polymers to form a three- 
dimensional complex structure resembling the putative “egg-box” model (Grant et al., 
1973). Our study explored the zinc ion as a potential crosslinker. A microsphere-type 
system was developed (referred to as a "gelisphere") with drug entrapped within the 
crosslinked matrix.
The overall aim of this study was to design an ionotropically crosslinked zinc-alginate- 
pectinate system for rate-adjusted drug delivery. Specifically, we set out to synthesize
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statistically-based crosslinked gelispheres using a Box-Behnken design, study their drug 
release behaviour, establish the degree of crosslinking using textural profiling analysis, 
and assess the viscoelastic transitions within the native polymers and crosslinked matrix.
5.2 Materials and Methods
The sodium alginate and pectin are of the same grade as those used in Chapter 4. Zinc 
sulphate heptahydrate, zinc gluconate USP and ibuprofen USP were purchased from 
Spectrum (USA).
5.2.1 Calibration Curves of Ibuprofen in Buffer Media of pH 3 and pH 6.8
Standard for solutions of ibuprofen were prepared by dissolving appropriate quantities of 
drug in USP-recommended buffers (0.0052, 0.0136, 0.0252, 0.0504 and 0.0608mg/ml in 
buffer pH 3; 0.00625, 0.0125 and 0.025mg/mL in buffer pH 6.8).
The absorbance values of the standard solutions were determined by UV at the 
wavelength maximum of 221 nm. Using this information, the calibration curves in buffer 
media pH 3 and 6.8 were constructed (Figures 5.3 and 5.4). Note that the buffer, 
polymers and excipients did not show any absorbance readings or interference at 221 nm.
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Concentration (mg/ml)
Figure 5.3 Calibration curve of ibuprofen in USP-recommended buffer of pH 3. (In 
all cases it was observed that SDs<0.03 were obtained, N=3).
Concentration (mg/ml)
Figure 5.4 Calibration curve of ibuprofen in USP-recommended buffer of pH 6.8. (In 
all cases it was observed that SDs<0.02 were obtained, N=3).
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Gelispheres loaded with ibuprofen were formulated in accordance with a Box-Behnken 
design having polymer and crosslinking agent concentrations as depicted in Tables 5.1 
and 5.2. A similar approach discussed in Chapter 4 was used to develop the 
Experimental Design.
5.2.2 Formulation of Crosslinked Zinc-Alginate-Pectinate Geiispheres
Table 5.1 Normalized Factor Levels of the Independent Variables for the Box- 
Behnken Design___________________________________________________________
Variable Factor Level Units
-1 1
Sodium Alginate 0 2 % w/v
Pectin 0 2 % w/v
Zinc Sulphate Heptahydrate 0 5 % w/v
Zinc Gluconate USP 0 5 % w/v
A quantity of sodium alginate and/or pectin, and ibuprofen (2:1) was added to deionised 
water, made up to volume (100mL) and homogenized to form a polymer-drug suspension 
(Vortex Mixer model 947, England). The crosslinking solution was prepared by dissolving 
an appropriate quantity of zinc sulphate heptahydrate and/or zinc gluconate (see Tables
5.1 and 5.2) in deionised water and made up to 1000mL. Gelispheres were formed by 
titrating the above polymer-drug suspension at 2mL/minute into the crosslinking solution 
by means of a 6-channel peristaltic pump (Desaga, Heidelberg) fitted with Pharmed® 
tubing (Cole-Parmer, USA) having a flat-tip 19-gauge needle opening. On completion of 
the titration process, the formed gelispheres were agitated in the crosslinking solution for 
an additional 30 minutes. Thereafter, the gelispheres were allowed to cure under dark 
conditions (21 °C) for a 24-hour period. Following this curing phase, the crosslinking 
solution was decanted and the gelispheres were washed with 3x500mL volumes of 
deionised water. The gelispheres were then air-dried at 21 °C for 48 hours under an 
extractor.
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Table 5.2 Box-Behnken Matrix for the Formulation of the Zinc-Alginate-Pectinate
Gelispheres
Gelisphere
Formulation
(F#)
Sodium
Alginate
(%w/v)
Pectin (%w/v)
Zinc Sulphate 
Heptahydrate 
(%w/v)
Zinc
Gluconate
(%w/v)
1 0 1 2.5 0
2 1 0 2.5 5
3 1 1 5 5
4 1 1 0 0
5 0 0 2.5 2.5
6 2 0 2.5 2.5
7 1 2 2.5 0
8 1 1 2.5 2.5
9 0 2 2.5 2.5
10 0 1 5 2.5
11 1 0 2.5 0
12 1 2 5 2.5
13 1 0 0 2.5
14 1 1 2.5 2.5
15 2 1 5 2.5
16 1 1 0 5
17 1 1 2.5 2.5
18 2 2 2.5 2.5
19 1 2 0 2.5
20 1 0 5 2.5
21 1 1 2.5 2.5
22 1 2 2.5 5
23 0 1 0 2.5
24 2 1 0 2.5
25 2 1 2.5 0
26 0 1 2.5 5
27 2 1 2.5 5
28 1 1 5 0
The quadratic response model with 15 terms generated from the above design included 
24 experimental runs and 4 centre points (Equation 5.3):
Response = b0 + bZNaAl + b2*P + b3*ZnS + b4*ZnG + bs*NaArNaAI + b6*P*P + 
b7*ZnS*ZnS + b8*ZnG*ZnG + bg*NaAI*P + b10*NaAI*ZnS + b11*NaAt*ZnG + b12*P*ZnS + 
b13*P*ZnG + b14*ZnS*ZnG (Equation 5.3)
where the concentrations of sodium alginate and pectin are represented by NaAl and P, 
and the concentrations of the crosslinkers ZnS04.7H20  and C12H22Zn014 are represented 
by ZnS and ZnG. b0...... b14 are the regression coefficients.
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5.2.3 Determination of Drug Encapsulation Efficiency within the Gelispheres
Actual drug loading was determined by dissolving 50mg of gelispheres in 100mL 
phosphate buffer pH 6.8 and analysed by UV. Based on the theoretical drug loading, the 
encapsulation efficiency was computed in a manner similar to that described in Chapter 4 
(see Equation 4.3).
5.2.4 Textural Profile Analysis on Crosslinked Zinc-Alginate-Pectinate Gelispheres
This study focused on the characterization of the matrix resilience (hydrated), rupture 
energy and yield value of the gelispheres using TA.XT.plus Texture Analyzer (Stable 
Micro Systems, England) fitted with a 36mm cylindrical steel probe and a 5kg load cell. 
The techniques used to evaluate the above parameters were performed in a manner 
similar to that described in Chapter 4. Below are typical profiles used for the calculation of 
these parameters (Figure 5.5).
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Figure 5.5 Typical textural force-time and force-distance profiles of crosslinked 
zinc-alginate-pectinate gelispheres for the determination of (a) Matrix resilience (b) 
Rupture energy, and (c) Yield value. (In all cases it was observed that SDs<0.1 were 
obtained, N=10).
86
5.2.5 Viscoelastic Studies
This study was conducted using a Brookfield’s Viscometer (Model RV, spindle #2) in order 
to characterize the viscoelastic transitions of polymers on the incremental addition (pi) of 
different crosslinkers to polymer/drug combinations, as indicated below (Table 5.3). The 
homogenized polymer/drug suspensions were gently magnetically stirred. The 
polymer/drug combinations employed included 1%w/v each of alginate and/or pectin. 
These combinations, when studied in the presence of drug, contained 0.5%w/v ibuprofen. 
The crosslinking solutions included 2.5%w/v each of zinc sulphate heptahydrate and/or 
zinc gluconate.
The polymer/drug suspension was added to a 250mL beaker and magnetically stirred for 
5 minutes. Thereafter the beaker was removed from its stirring position and the viscosity 
of the suspension was tested at 50 rpm. Two minutes were allowed for the viscometer 
reading to stabilize before any readings were taken. The polymer/drug suspension was 
replaced on the stirrer and 500pl of the crosslinker solution was added, allowed to stir for 
a further 5 minutes after which the viscosity was tested.
18 combinations of polymer/drug and crosslinker combinations were studied as indicated 
below (Table 5.3).
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Table 5.3 Polymer-Crosslinker Combinations Used to Assess the Viscoelastic
Transitions
Experimental
Run
[NaAl]
(%w/v) [P] (%w/v)
[Ibuprofen]
(%w/v)
[ZnS]
(%w/v)
[ZnG]
(%w/v)
1 1 0 0.5 2.5 0
2 1 0 0.5 0 2.5
3 1 0 0.5 2.5 0
4 0 1 0.5 2.5 0
5 0 1 0.5 0 2.5
6 0 1 0.5 2.5 2.5
7 1 1 0.5 2.5 0
8 1 1 0.5 0 2.5
9 1 1 0.5 2.5 2.5
10 1 0 0 2.5 0
11 1 0 0 0 2.5
12 1 0 0 2.5 2.5
13 0 1 0 2.5 0
14 0 1 0 0 2.5
15 0 1 0 2.5 2.5
16 1 1 0 2.5 0
17 1 1 0 0 2.5
18 1 1 0 2.5 2.5
5.2.6 In Vitro Dissolution Studies
In vitro dissolution studies were conducted using the USP 25 rotating paddle method at 
50rpm in buffer medium pH 6.8 maintained at 37°C. The method was modified using a 
ring-mesh assembly, previously described by Pillay and Fassihi (1998). Samples were 
withdrawn at predetermined time intervals via an autosampler (Hewlett-Packard).
5.3 Results and Discussion
5.3.1 Drug Encapsulation Efficiency
The lowest and highest encapsulation was obtained from formulations F21 and F24 
respectively i.e. 37.19% and 82.96%. In the case of F21, this may be attributed to the 
interference by the pectin monomers and a reduction in the zinc gluconate concentration 
(see Table 5.4) This could lead to a more open (porous) crosslinked lattice, and thus 
allowing for the escape of drug into the crosslinking solution during the curing phase. In 
the case of F24, alginate is highly crosslinked by zinc sulphate heptahydrate (preliminary
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studies) and hence provides a three-dimensional network with greater crosslinker density, 
hence entrapping significantly more drug.
Table 5.4 Drug Encapsulation Efficiency from the Various Statistically-Designed 
Zinc-Alginate-Pectinate Gelispheres__________________________________________
Formulation 
Number (F#)
Drug
Encapsulation 
Efficiency (%) Mean (%) Standard Deviation (SD)
Sample
1
Sample
2
1 64.49 64.01 64.25 0.34
2 76.36 75.82 76.09 0.38
3 55.73 54.65 55.19 0.76
4 - - - -
5 - - -
6 68.87 65.93 67.40 2.08
7 77.68 74.21 75.94 2.46
8 56.27 56.45 56.36 0.13
9 55.67 54.83 55.25 0.59
10 49.37 48.77 49.77 0.42
11 73.49 72.65 73.07 0.59
12 62.09 65.33 63.71 2.29
13 69.77 66.05 67.91 2.63
14 58.85 58.01 58.42 0.59
15 64.49 65.63 65.21 1.02
16 55.07 56.09 55.58 0.72
17 44.69 48.05 46.37 2.38
18 67.49 66.41 66.95 0.76
19 72.47 76.66 74.57 2.97
20 60.89 63.83 62.36 2.08
21 37.85 36.53 37.19 0.93
22 48.17 48.71 48.44 0.38
23 53.87 55.43 54.65 1.1
24 83.08 82.84 82.96 0.17
25 72.65 72.05 72.35 0.42
26 40.97 36.95 38.96 2.84
27 60.47 60.71 60.59 0.17
28 55.85 55.37 55.61 0.34
5.3.2 Textural Profiling Analysis of Crosslinked Gelispheres
The crosslinked gelispheres were spherical in shape with a uniform diameter of about 
1.5mm. Macros created on Texture Exponent Version 3.2 were run on the textural 
profiles to calculate various parameters: namely, matrix resilience, rupture energy and 
matrix yield value.
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Figure 5.6 Hydrated matrix resilience for the 28 Box-Behnken designed 
formulations. (In all cases it was observed that SDs<0.25 were obtained, N=10).
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Figure 5.7 Matrix rupture energy for the 28 Box-Behnken designed formulations. (In 
all cases it was observed that SDs<0.007 were obtained, N=10).
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Figure 5.8 Matrix yield value for the 28 Box-Behnken designed formulations. (In all 
cases it was observed that SDs<0.9 were obtained, N=10).
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It is distinctly apparent that the textural properties of the crosslinked gelispheres are 
significantly influenced by altering the concentration and polymer/drug and crosslinker 
concentrations. This may be attributed to the different degrees of crosslinking achieved 
under different conditions.
5.3.3 Viscoelastic Behaviour of Crosslinked Gelispheres
Four different and distinct viscoelastic patterns were observed during in situ crosslinking 
of polymer solutions (Figure 5.9).
Crosslinker Addition (ul)
Figure 5.9 Typical viscoelastic behaviour observed among the 28 formulations. The 
four distinct patterns observed are (a) Bell-shaped, (b) Hyperbolic, (c) Sigmoidal, 
and (d) Modified bell curve (anomalous distribution).
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Figure 5.9a indicates an initial slow rate of change in the viscoelasticity of the polymers 
involved. Upon reaching a threshold crosslinker value of approximately 2000pl, the rate 
of polymeric entanglement rapidly progressed and peaked at 1300cP. Subsequent 
addition of the crosslinker indicated a rapid decline in the viscoelasticity which is attributed 
to an aqueous dilution effect of the entire polymeric system (Pillay and Fassihi, 1999b; 
Pillay et al., 2002). This was not a reflection of chain disentanglement.
Figure 5.9b indicates a large lag-phase prior to any change in the viscoelasticity. The 
threshold value in this case was approximately 6500|il, indicating a significantly higher 
resistance to chain stiffening, contrary to that observed in Figure 5.9a.
The threshold for chain stiffening shown in Figure 5.9c is very similar to that observed in 
Figure 5.9b (5500pl). However, viscoelasticity steadily increased over numerous titrations 
of the crosslinker and peaked at 416cP. At the maximum, the viscoelasticity remained 
constant despite additional crosslinker. This may be attributed to an influx of the 
crosslinking ions into the spongy, absorbent matrix and hence accounts for an absence of 
the aqueous dilution effect seen in Figure 5.9a.
Figure 5.9d exhibits behaviour very similar to that seen in Figure 5.9a, except that after 
the aqueous dilution phase, beginning from 600cP, the crosslinked matrix tends to 
become spongy at 350cP and significantly absorbs the crosslinking ions. Hence no 
change in viscoelasticity was observed.
5.3.4 In Vitro Dissolution Behaviour
This study indicated significantly different dissolution profiles derived for the 28 
formulations, which may be attributed to the significantly different degrees of crosslinking 
achieved in each case.
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Figure 5.10 Dissolution profiles for the 28 gelisphere formulations in phosphate 
buffer pH 6.8. (In all cases it was observed that SDs<0.07 were obtained, N=3).
The primary aim of this study was to select a candidate formulation from the 28, in terms 
of the following criteria:
(i) Absence of burst effect,
(ii) Possible initial lag phase in the release process,
(iii) Slowest release rate, and
(iv) Attainment of a plateau at a very low level of drug release e.g. at 10% drug release.
Based on the above criteria as a selection tool for the candidate formulation, F9 fulfilled 
the above objectives. Chapter 6 would introduce a newly synthesized crosslinked
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polymer that would be used to further investigate the manipulation of the physicochemical 
properties of F9. The focus of Chapter 6 is to outline the synthesis and sensitivity of this 
new crosslinked polymer.
5.4 Concluding Remarks
We have indicated that the degree of polymeric crosslinking can considerably change 
both the physicochemical and physicomechanical properties of the zinc-alginate-pectinate 
gelispheres. Contrary to Chapter 4, the aim of Chapter 5 was not to undertake 
formulation optimization by traditional regression analysis. The primary aim of Chapter 5 
was to obtain a candidate formulation (namely F9) which could be further manipulated 
employing the new crosslinked polymer synthesized in our laboratory. The sequential 
approach towards optimization of this crosslinked polymer will be demonstrated in 
Chapter 6, while its utility as a release rate-modulating agent of F9 will be elucidated in 
Chapter 7.
95
Chapter Six
Synthesis and Sensitivity of a Novel Crosslinked Ethylenic Homopolymer 
Derived from Native Polyvinyl Alcohol
6.1. Introduction
Chapter 5 generated a primary formulation to be further optimized through the addition of 
a newly synthesized polymer. This new material, derived from native polyvinyl alcohol 
(PVA) as the starting compound, has to date never been synthesized by any other 
research group and applied in drug delivery in the described manner. The new material is 
referred to as a “crosslinked ethylenic homopolymer” (CEH). CEH will initially be 
formulated as gelispheres prior to its use as a release rate-modulating agent. The current 
Chapter details its synthesis, physicochemical and physicomechanical sensitivity, and 
numerical optimization.
A thorough literature survey on the application of PVA in drug delivery was conducted, 
and the relevant information is henceforth presented. PVA and its copolymers have found 
various applications in controlled drug release (Diluccio et al., 1994; Orienti et al., 2000; 
Soppimath et al., 2000; Doria-Serrano et al., 2001; Orient et al., 2001). Despite their 
higher water content, PVA hydrogels have been reported to be useful for the release of 
both hydrophobic and hydrophilic drugs. Since PVA is hydrophilic and easily swells upon 
hydration, some grades of PVA (based on molecular weight), have shown volume 
expansion up to 500% at 37°C. However, this expansion can be inhibited by swelling 
controlling agents, namely electrolytes. Based on this unique property of PVA, different 
types of controlled release systems can be developed, whereby the release rate is 
controlled by the content of PVA, swelling controlling agent in the matrix core, and the 
application of coating films (Morita et al., 2000). At the initial stage of drug release, the 
rate is determined by water permeation through the membrane. However, when the
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membrane bursts as a result of swelling, the release rate is controlled by the PVA matrix, 
which typically produces traditional first order and square root kinetics. The attainment of 
such release behaviour is no longer a challenge to pharmaceutical scientists.
To prolong drug release from the inherently hydrophilic polymer network, PVA may be 
modified by crosslinking to reduce the macromolecular pore size available for drug 
diffusion. The crosslinking process can be carried out either before or after drug loading, 
the former process being preferred since further possible side reactions between the drug 
and crosslinking agent may additionally reduce its diffusion (Korsmeyer and Peppas, 
1981; Ahlin et al., 2002).
PVA can also be crosslinked by ultra-violet irradiation on its surface to produce prolonged 
drug delivery (Colombo et al., 1987). This irradiation in conjunction with chemical 
reactions can also be used to prepare hydrogel membranes. In addition, PVA has been 
classically crosslinked by glutaraldehde and ethylene glycol dimethacrylate to prepare 
microspheres and interpenetrating networks (Peppas and Wright, 1998; Gohel and Amin, 
1999).
Crosslink density affects the size of the macromolecular pores of the hydrogel network 
and thus the water content, which is responsible for the transport (efflux) of solute 
molecules (Pillay et al., 2002). The diffusion coefficient can be linearly increased for 
solute molecules by increasing water content in the hydrogel, indicating that diffusion 
occurs primarily through hydration of the network (Burczak et al., 1994).
Most commonly, PVA has been used as a surfactant in the formulation of polylactic co- 
glycolic acid (PLGA) microparticles. In this case PVA influences different pharmaceutical 
properties of the microparticles, such as size, zeta potential, polydispersity index, surface 
hydrophobicity, drug loading and in vitro release of encapsulated molecules (Shameem et
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al., 1999; Soppimath et al., 2000; Sahoo et al., 2002).
It is well known that the reaction between PVA and boric acid results in an incompatibility 
which produces a “slime”. However, to date, this reaction in this context has not been 
further explored to synthesize a “useful slime”. This became the objective of this part of 
the study. Based on the Hofmeister series, various inorganic ions were tested to modify 
the physicochemical properties of the PVA slime, namely thiocyanates, nitrates, chlorides, 
citrates, acetates, phosphates, sulphates, calciums, magnesiums, sodiums, potassiums 
and ammoniums. In addition a series of organic crosslinkers were evaluated. The 
overriding motive was to optimize this slime such that a crosslinked ethylenic 
homopolymer (CEH) could be formed and used to modify the candidate zinc-pectinate 
system (F9) in order to achieve zero-order drug release over an extended period of time. 
Theophylline was employed as the model drug.
6.2 The Specificity of Our Discovery
We discovered that instead of a slime, an aqueous solution of specific ratios of inorganic 
agents boric acid and sodium sulphate heptahydrate when reacted with PVA results in a 
rapid salting-out/crosslinking phenomenon. This process could be facilitated by the 
addition of prescribed organic crosslinkers such that a desirable plastically-deforming, 
rubbery material was the end product.
6.3 Materials and Methods
Theophylline was purchased from Fluka Chemicals (Switzerland), PVA from Aldrich 
Chemical Company (USA) and boric acid, sodium sulphate heptahydrate, ammonia and 
n-propanol were obtained from Rochelle Chemicals (South Africa).
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6.3.1 Preformulation Study
6.3.1.1 Calibration Curve of Theophylline in Water and Buffer Media of pH 6.8
Theophylline was dissolved in deionised water and phosphate buffer pH 6.8 to produce a 
series of standard solutions: 0.0004, 0.0008, 0.001, 0.0012, 0.0014 and 0.0018mg/mL. 
Their absorbance values were determined at the wavelength maximum of 271 nm. Using 
this information the calibration curves were constructed (Figure 6.1). No significant 
difference was found between the regression lines (p>0.05). This may be due to the fact 
that theophylline demonstrates pH-independent solubility. Hence one calibration curve 
was statistically feasible for use under both conditions.
Concentration (mg/mL)
Figure 6.1 Calibration curve of theophylline in deionised water and phosphate 
buffer pH 6.8 (p>0.05). (In all cases it was observed that SDs<0.001 were obtained, 
N=3).
6.3.1.2 Preparation of CEH Gelispheres
A 2:1 PVA-theophylline aqueous suspension was made up to 100mL. This suspension 
was thereafter titrated into a crosslinking solution comprised of different concentrations of
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boric acid, sodium sulphate heptahydrate, ammonia and n-propanol.
The resulting gelispheres were allowed to stir in the crosslinking solution for a further 30 
minutes, after which they were placed in a dark area to cure for a period of 24 hours. At 
the end of this period the CEH gelispheres were washed with 3x500mL deionised water 
and air-dried under an extractor for 48 hours.
6.3.1.3 Size Analysis of Gelispheres
The size of the gelispheres were determined using a vernier calliper (N=10).
6.3.1.4 Drug Loading and Encapsulation Efficiency
Drug loading was conducted by dissolving 50mg of CEH gelispheres in 100mL deionised 
water. Based on the theoretical drug loading, the encapsulation efficiency was computed 
in a manner similar to that described in Chapter 4.
6.3.1.5 In Vitro Dissolution Studies
Drug release studies were conducted using a modified method of the USP 25 employing 
a ring mesh assembly (Pillay and Fassihi, 1998) in deionised water at 50rpm (N=3). At 10 
minute intervals, samples were removed by an automated system described in Chapter 5 
and analysed by ultraviolet spectroscopy at 271 nm. Deionised water was selected as the 
dissolution medium so as to account for the sole behaviour of the CEH system in the 
absence of any interfering ions (e.g. phosphate buffer ions). In cases where dilution of 
samples was required, an appropriate correction factor was employed.
6.3.1.6 Textural Profiling Studies
The textural properties, namely matrix fracture energy, fracture force and hardness were 
measured in a manner similar to that illustrated in Chapter 4 (Texture Analyzer, Stable 
Micro Systems, England).
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6.4 Results and Discussion
6.4.1 Crosslinking of PVA to Produce the CEH Gelispheres
6.4.1.1 Influence of Preformulation Levels of Inorganic Crosslinkers Boric Acid and 
Sodium Sulphate Heptahydrate
In order to firstly explore the crosslinking phenomenon of PVA in the presence of boric 
acid and sodium sulphate heptahydrate, gelisphere formation was attempted by titration 
of an aqueous PVA solution into a solution, as illustrated in Table 6.1. Based on 
Preformulation studies, various concentrations of each component were selected to 
provide significantly different results.
Table 6.1 Preliminary Selection of Concentrations of PVA and Initial Crosslinker 
Combination of Boric Acid and Sodium Sulphate Heptahydrate for the Formation of 
CEH gelispheres___________________________________________________________
Components Concentrations (%w/v)
Polymer: PVA 0.25 1 4 6
Inorganic Crosslinkers
Boric Acid 0.25 1 5 15
Sodium Sulphate
Heptahydrate 0.25 1 5 15
Physical Observation
No No Aggregated No
gelispheres gelispheres weak aggregation,
formed formed gelispheres irregularly
formed. shaped,
Dissolved in weak,
crosslinkers gelispheres
within 2 formed.
hours Dissolved in
crosslinkers
within 2
hours
Based on the above study, the following concentrations of PVA and crosslinkers were 
selected: 6%w/v PVA and 15%w/v each of boric acid and sodium sulphate heptahydrate. 
The range of organic solvents selected (Table 6.2) significantly affected the ability of the 
gelispheres to form. In general, aggregated and irregulany shaped gelispheres were 
formed and then dissolved in the crosslinkers within 2 hours, irrespective of the volume 
(10-70mL), except for those formulated in n-propanol and ammonia.
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6.4.1.2 Influence of Preformulation Levels of Organic Solvent Crosslinkers
Table 6.2 Preliminary Selection of Organic Solvents for CEH Gelisphere Production in Combination with 15%w/v each of Boric Acid
Volume (mL)
1 2 3 4 5 6 7 8 9 10 11 12 13
Chloroformate 10-70 0 0 0 0 0 0 0 0 0 0 0 0
Butaraldehyde 0 10-70 0 0 0 0 0 0 0 0 0 0 0
Glyoxal 0 0 10-70 0 0 0 0 0 0 0 0 0 0
Hydroxyadipaldehyde 0 0 0 10-70 0 0 0 0 0 0 0 0 0
Urea-Formaldehyde 0 0 0 0 10-70 0 0 0 0 0 0 0 0
Melamine-Formaldehyde 0 0 0 10 0 10-70 0 0 0 0 0 0 0
Zinc Zirconium Carbonate 0 0 0 0 10 0 10-70 0 0 0 0 0 0
Acetone 0 0 0 0 0 10 0 10-70 0 0 0 0 0
Chloroform 0 0 0 0 0 0 10 0 10-70 0 0 0 0
Methylene Chloride 0 0 0 0 0 0 0 10 0 10-70 0 0 0
n-Propanol 0 0 0 0 0 0 0 0 10 0 10-70 0 0
Ammonia (25% Strength) 0 0 0 0 0 0 0 0 0 10 0 10-70 0
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6.4.1.3 Selection of Final Polymer and Crosslinker Combination for the Production 
of Spherical Discrete CEH Gelispheres
Based on the observations in Table 6.2, it was apparent that separate 10mL volumes 
each of n-propanol and ammonia produced superior results when compared to the other 
organic solvents. A minimum volume of 10mL was selected in each case in order to 
minimize remaining residual quantities within the gelispheres. Hence the following 
combination of components was further tested for gelisphere production (Table 6.3).
Table 6.3 Polymer and Crosslinker Combination for the Production of CEH 
Gelispheres_______________________________________________________________
Components Quantity (mL) Concentration (%w/v)
PVA 100 6
Boric Acid 100 15
Sodium Sulphate 
Heptahydrate 100 15
n-Propanol 10
Ammonia (25% Strength) 10 -
Observation Spherical Discrete Robust Gelispheres Formed
6.4.2 Evaluation of the Physicochemical and Physicomechanical Properties of the 
Gelispheres Using a Box-Behnken Design with Pre-Determined Low and High 
Statistical Levels of the Crosslinkers
In order to quantitatively understand the dynamics of the crosslinking process of native 
PVA in the proposed inorganic and organic combination, we opted to build a Box- 
Behnken Experimental Design (Table 6.4).
Based on the preliminary experiments the lower and upper factor levels for the 
concentrations of crosslinkers were as follows: boric acid and sodium sulphate 
heptahydrate (5-15% w/v) and, ammonia and n-propanol (10-70mL).
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Table 6.4 Box-Behnken Design to Establish the Physicochemical and 
Physicomechanical Properties of the CEH Gelispheres_____________
Experimental
Number
Boric
Acid
(% w/v)
Sodium
Sulphate
Heptahydrate
(%w/v)
Ammonia
(mL)
n-Propanol
(mL)
1 10 10 5 10
2 5 5 10 70
3 10 10 10 40
4 10 10 5 40
5 10 10 10 40
6 5 5 15 40
7 10 10 10 10
8 10 10 5 70
9 15 15 10 70
10 15 15 10 40
11 15 15 15 40
12 10 10 10 40
13 10 10 5 40
14 15 15 5 40
15 10 10 10 10
16 5 5 10 40
17 5 5 10 10
18 15 15 10 40
19 15 15 10 10
20 10 10 15 40
21 10 10 15 70
22 10 10 15 10
23 10 10 10 40
24 10 10 15 40
25 5 5 10 40
26 10 10 10 40
27 5 5 5 40
28 10 10 10 70
29 10 10 10 70
The general quadratic response function (Equation 6.2) for the design encompassed 15 
terms with 4 factors and 5 centre points:
Response = b0 + b,*A + b2*B + b3*C + b4*D + bs*A*A + b6*B*B + b7*C*C + b8*D*D + 
b9*A*B + b10*A*C + bu *A*C + b12*B*C + b13*B*D + bu *C*D (Equation 6.2)
where A, B, C and D represent the concentrations (%w/v) and volumes (ml_) of boric acid, 
sodium sulphate heptahydrate, ammonia and n-propanol, respectively.
The responses that were measured included size (mm), drug encapsulation efficiency
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(%), dissolution after 30 minutes (t3omin) (%), fracturability (N) and fracture energy (J) 
required for matrix rupture. The following quadratic equations were generated to predict 
each of these responses:
Size = 2.44 + 0.21 *A + 0.030*B + 0.33*C+0.13*0+0.21 *A2+0.057*B2+0.14*C2 + 0.19*D2 + 
0.23*A*B + 0.3 5*A* C + 0.20*A*D + 0.080B*C + 0.27*C*D
Root MSE = 0.26, OF = 10 (Equation 6.3)
Drug Encapsulation Efficiency = 25.05 + 8.72*7.68*B + 15.57*C + 4.24*D +1.23*A*A + 
4.21 *B*B + 2.63* C*C + 8.46*D*D + 11.10*A*B + 10.55*A*C + 3.32*A*D + 8.73*B*C + 
0.86*B*D + 13.08*C*D
Root MSE = 17.24, DF = 10 (Equation 6.4)
Dissolution (t30min) = 50.12+ 5.66*A + 6.73*B + 11.76*C7.12*D + 2.54*A*A + 10.50*B*B + 
1.10*C*C + 14.94*D*D + 9.04*A*B + 7.72*A*C + 2.83*A*D + 4.52*B*C + 24.25*B*D + 
2.50*C*D
Root MSE=19.55, DF=10 (Equation 6.5)
Fracturability = 48.09 + 2.96*A* + 2.70*B + 12.65*C + 0.80*D + 1.06*A*A + 5.30*B + 
1.09*C*C + 7.73*D*D + 8.85*A*B* + 8.6*A*C + 0.90*A*D* + 3.33*B*C + 7.95*B*D + 
3.25*C*D
Root MSE=22.22, DF= 10 (Equation 6.6)
Fracture Energy = 0.012 + 9.109x1 U4*A + 1.977x10'3*B + 3.083x10 3*C + 1.477x10'S*D + 
2.208x10 3*A*A + 3.124x10'3*B2 + 3.464x10'3*C2 + 5.105x10'4*D*D + 2.003x1 O'3 *A*B + 
5.020x10'4*A*C + 4.800x10 3*A*D + 4.515x10 3*B*C* + 1.943x1 O'3 *B*D + 5.35910'3*C*D 
Root MSE=9.234x1 O'3, DF=10 (Equation 6.7)
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In the above equations MSE = Mean Square Error, DF = Degrees of Freedom and t30min = 
percentage drug dissolution after 30 minutes.
6.4.3 Variability in the Physicochemical and Physicomechanical Properties of the 
CEH Geiispheres
Table 6.5 and Figure 6.2 indicate the different experimental values derived for the 
selected responses.
Table 6.5 Experimental Responses for the 29 Statistical CEH Geiispheres
Formulatior 
Number (F#
Experimental Response Values
l
) Size (mm)
Drug
Loading
(%)
Fracturability
(N)
Fracture
Energy
(Joules)
Fractional
Dissolution
( t 3 0 m in )
1 1.99 9.83 49.91 0.014 0.647
2 2.00 11.72 45.57 0.017 0.784
3 2.02 13.57 75.57 0.021 0.769
4 2.40 35.43 38.54 0.018 0.248
5 1.66 73.60 45.13 0.013 0.322
6 2.28 9.77 12.64 0.001 0.747
7 1.77 8.28 16.00 0.006 0.726
8 1.39 8.11 41.19 0.006 0.658
9 1.97 18.09 24.33 0.005 0.206
10 1.94 10.65 53.65 0.011 0.533
11 1.13 9.77 34.72 0.004 0.868
12 1.17 7.30 48.16 0.006 0.662
13 0.99 9.93 36.09 0.016 0.936
14 1.36 11.84 35.10 0.010 0.903
15 2.31 61.34 25.06 0.013 0.423
16 2.50 22.47 31.02 0.008 0.565
17 1.00 14.51 66.48 0.020 1.057
18 1.10 7.76 46.07 0.006 0.760
19 2.50 48.97 32.86 0.016 0.199
20 2.50 11.69 17.52 0.001 0.527
21 3.00 64.37 36.40 0.012 0.373
22 2.50 15.02 23.12 0.002 0.604
23 2.50 8.65 26.98 0.003 0.638
24 2.00 5.81 95.54 0.023 0.471
25 2.10 4.60 86.11 0.029 0.491
26 3.00 46.25 37.71 0.020 0.448
27 2.00 53.38 29.17 0.010 0.306
28 Irregular 2.50 45.13 0.031
29 Irregular 2.00 - 37.34 0.014
homin indicates fractional dissolution after 30 minutes
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Figure 6.2 Inter-formulation variations in responses for the CEH gelispheres: (a) 
Size, (b) Drug encapsulation, (c) Fracturability, (d) Fracture energy, and (d) (e) 
Fractional dissolution after 30 minutes ( t 30m in)- (In all cases it was observed that 
SDs<0.07 were obtained, N=10 except for dissolution where N=3).
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6.4.4 Statistical Fit of Parameters for Optimization of the CEH Geiispheres Derived 
from Native PVA
Using a modification of the constrained settings in conjunction with solving simultaneous 
equations on Design Expert Version 6 (Stat-Ease, USA), the CEH geiispheres were 
optimized. Tables 6.6 and 6.7 provide the indicators of the model stability.
Table 6.6 Statistical Power of the Quadratic Model
Parameters Degrees of Freedom
Model 14
Residuals 14
Lack of Fit 10
Pure Error 4
Correlation Total 28
Table 6.7 Efficiency of the Quadratic Model
Parameters Goodness-of-Fit
Average Leverage 0.517
Maximum Prediction Variance 0.583
Average Prediction Variance 0.517
G-Efficiency 88.70%
Scaled D-Optimality Criterion 5.153
Condition Number 1.933
6.4.5 Numerical Optimization
The matrix design was optimized to produce a model capable of generating set goal 
values for the responses as indicated in Table 6.8. Table 6.9 depicts the 10 significant 
solutions generated after 5000 iterations.
Table 6.8 Theoretical Goals Set for Optimization of the Combined Response
Surface Model______________________________________________
______________Parameter_______________________________ Goal
Boric Acid (%w/v) 5-15
Sodium Sulphate Heptahydrate(%w/v) 5-15
Ammonia (ml.) 10-70
n-Propanol (ml_) 10-70
Size (mm) 1.8-3.8
Drug Encapsulation (%) 90
Dissolution (t30min) 10
Fracturability (N) >96
________Fracture Energy (Joules)________________________ >0.031
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Table 6.9 Predicted Solutions Derived from the Combined Response Surface Model
Solution Formulation Parameters
A B C D Size DE Diss F FE Des
1 15 12 10 11 3.6 79.4 28 30 0.021 0.562
2 15 12 10 11 3.6 80 28 30 0.021 0.562
3 15 15 10 10 3.6 89 12 93 0.051 0.891
4 15 12 11 10 3.5 78 28 31 0.021 0.561
5 15 12 12 12 3.5 77 28 31 0.021 0.561
6 15 12 14 10 3.4 74.4 28 32 0.020 0.558
7 15 12 10 18 3.6 78.1 28 31 0.020 0.556
8 15 12 15 17 3.5 73.4 26 33 0.019 0.555
9 5 14 10 31 2.6 33.6 32 42 0.019 0.486
10 5 7 70 55 2.8 21.1 72 44 0.026 0.381
A = Boric acid (%w/v), B = Sodium sulphate heptahydrate (%w/v), C = Ammonia (mL), D = n- 
propanol (mL), DE = Drug Encapsulation (%), Diss = Drug dissolution after 30 minutes (t30m:„), F  = 
Fracturabiiity (N), FE = Fracture Energy, and Des = Desirability function indicating the predictive 
power of achieving the best experimental response.
Based on the desirability function of 0.891, it is apparent that Solution 3 may provide the 
best experimental outcome.
A CEH gelisphere formulation was prepared according to Solution 3 and the necessary 
experimental responses were measured (Table 6.10).
Table 6.10 Comparison of Experimentally-Derived Responses with those
Statistically Predicted from Solution 3________________________________________
_______Responses from Predicted Solution and Experimental Study______
Formulation Size Dissolution Fracturabiiity Fracture
_______________ (mm) Encapsulation ^  ,N, Energy (J)
Predicted 
Statistical 
Solution 3
3.60 89 12 93 0.051
Experimental
Solution
3.72 92.95 8.60 82.39 0.032
Note: Optimized experimental formulation is subsequently referred to as FD
6.5 Concluding Remarks
The Box-Behnken Design served as a useful tool to augment the various responses (size, 
drug encapsulation, dissolution, fracturabiiity and fracture energy) related to the CEH 
gelisphere system. Depending on the required behaviour of the system, as in the case of
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in vitro dissolution, the statistically-derived model for drug release was numerically solved 
to provide tailor-made release-rate modulation from the crosslinked system. The ensuing 
Chapter 7 of this study will focus on using the optimized CEH gelisphere formulation (FD) 
derived from numerical Solution 3 to control the release rate properties of the candidate 
zinc-pectinate formulation (F9) developed in Chapter 5.
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Chapter Seven
Application of the Crosslinked Ethylenic Homopolymer as a Drug Release 
Modifying Agent: It’s Effect on the Candidate Zinc-Pectinate Gelispheres
7.1 Introduction
In summary, we first tested the utility of Experimental Design using the Plackett-Burman 
matrix as an optimization tool. In order to develop a primary formulation for further 
manipulation, a high resolution Box-Behnken design was employed to develop zinc- 
alginate-pectinate gelispheres which would serve as a pool for the selection of a single 
formulation that be used as a candidate platform to test the influence of the novel 
crosslinked ethylenic homopolymer (CEH) synthesized from native PVA in Chapter 6.
The present Chapter explores the final stage of this research using a Face-Centred 
Central Composite Design (CCD) to optimize the candidate zinc-pectinate system with 
drug-free CEH gelispheres as a novel formulation excipient. This was performed by 
triturating the CEH gelispheres into a fine powder (5-12pm) and then incorporating it 
during the preparation of the zinc-pectinate matrix. The purpose of this task was to 
evaluate CEH as a potential release rate-modifying material.
The responses assessed in this optimization study included two significant formulation 
objectives, namely maximization of the drug encapsulation efficiency and modulation of in 
vitro drug release.
In addition, Differential Scanning Calorimetry (DSC), Fourier Transform Infra-Red (FTIR) 
and X-Ray Diffraction (XRD) studies were used to trace any characteristic 
physicochemical transitions within the polymeric matrices such as glass transition, drug 
melting endotherm, vibrations of molecular pendants and crystal disposition of the
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complex.
7.2 Methods and Materials
The materials and their source used in this part of the study can be found in previous 
chapters.
7.2.1 Formulation of CEH-Zinc-Pectinate Gelispheres
CEH was incorporated together with pectin and ibuprofen, and thereafter crosslinked. 
The crosslinking technique was similar to that described in Chapters 4, 5 and 6, except 
that a Face-Centred Central Composite Design was used with factors depicted in Tables
7.1 and 7.2. Note that the quantities of pectin, zinc sulphate and zinc gluconate were the 
same as that employed in Formulation F9 developed in Chapter 5 (see Figure 7.1 for 
original dissolution profile of F9).
Figure 7.1 Dissolution profile of the candidate zinc-pectinate gelisphere formulation 
F9.
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In this study ibuprofen (100mg) was substituted with theophylline (100mg), based on the 
fact that both drugs have a low solubility. However, theophylline behaves in a pH- 
independent manner (0.8% at 25°C). Ibuprofen on the other hand demonstrates pH- 
dependent solubility, increasing from acid to basic conditions with a minimum solubility of 
0.0078% to maximum solubility of 2.9% at 25°C. This transition was merely done to 
observe any changes in the dissolution profiles with drugs that have low solubility but 
exhibit different behaviour based on pH of the medium. In general, it is well-known that 
control of the release of pH-dependent drugs is a challenge.
The factor levels and experimental runs of the Face-Centred Design are depicted in 
Tables 7.1 and 7.2.
Table 7.1 Normalized Factor Levels of the Independent Variables for the Face- 
Centred Central Composite Design___________________________________________
Factor Level UnitsV  u l  I l l U I L
-1 1
CEH 0 0.1 %w/v
Crosslinking-Reaction Time 
(CRT)
2 24 hours
Drying Temperature (dT) 20 60 °C
Note: CEH (drug-free) was prepared using the numerically optimized quantities o f 6%w/v PVA, 
10%w/v each o f boric acid and sodium sulphate heptahydrate, and 15mL each of ammonia and n- 
propanol, as depicted for Solution 3 in Table 6.9.
The quadratic model comprised 3 factors and 5 centre points with 10 terms as shown 
below:
Response = b0 + b, *CEH + bz*CRT + b /d T  + b4*CEH*CEH + bs*CRT*CRT + bB*dT*dT + 
b7*CEH*CRT + bs*CEH*dT + b9*CRT*dT (Equation 7.1)
The abbreviations for terms CEH, CRT and dT are explained in Table 7.2. b0 to b9 are the 
regression coefficients.
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Table 7.2 Face-Centred Central Composite Design (CCD)
CEH Gelisphere 
Number
Crosslinked
Ethylenic
Homopolymer
(CEH)
Concentration
(%w/v)
Crosslinking 
Reaction Time 
(CRT) (hours)
Drying
Temperature (dT) 
(°C)
1 0.05 24 40
2 0.10 24 60
3 0.00 13 40
4 0.05 13 20
5 0.00 2 20
6 0.10 2 60
7 0.10 13 40
8 0.05 13 40
9 0.05 13 40
10 0.00 2 60
11 0.05 13 60
12 0.10 2 20
13 0.00 24 60
14 0.00 24 20
15 0.05 13 40
16 0.05 2 40
17 0.05 13 40
18 0.05 13 40
19 0.10 24 20
7.2.2 Determination of the Drug Encapsulation Efficiency of the CEH-Zinc-Pectinate 
Gelispheres
Drug loading was conducted by dissolving 50mg of CEH-zinc-pectinate gelispheres in 
100mL of USP-recommended phosphate buffer pH 6.8. Based on the theoretical drug 
loading, the encapsulation efficiency was computed in a manner similar to that described 
in Chapter 4.
7.2.3 In Vitro Dissolution Studies
In vitro dissolution studies were performed on the 19 formulations using the modified USP 
25 rotating paddle method at 37°C in phosphate buffer pH 6.8 at 50rpm, as described in 
Chapter 5.
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7.2.4 Differential Scanning Calorimetry (DSC) Studies
DSC studies were conducted on the drug, native polymers and 19 CEH-zinc-pectinate 
gelispheres. A linear temperature gradient at a rate of 5°C per minute was performed 
from 25°C to 400°C (Perkin Elmer Pyris-1). Samples of 5-1 Omg were placed within 
crimped aluminium pans and subjected to the test.
7.2.5 Fourier Transform Infra-Red (FTIR) Studies
FTIR studies were conducted on the drug, native polymers and 19 CEH-zinc-pectinate 
gelispheres at 21 °C (Nicolet Impact 400D). Samples of 7.5mg were mixed with 1.5g 
potassium bromide and triturated. From this mixture 150mg was compressed on a 
Beckman Hydraulic Press to produce a transparent disc. This disc was inserted into the 
spectrophotometer cell and its transmittance was read.
7.2.6 X-Ray Diffraction (XRD) Studies
XRD studies were conducted on the drug, native polymers and 19 CEH-zinc-pectinate 
gelispheres at 21 °C (Bruker D8 Advance Diffractometer). The measurement conditions 
were as follows: voltage 40kV, current 30mA, divergence slit 2mm, anti-scatter slit 0.6mm, 
detector slit 0.2mm, scanning speed: 2° per minute (step size 0.025°) and step time 1.0 
second. Approximately 200mg of a CEH gelisphere sample was loaded into an 
aluminium holder and subjected to the test, taking care not to introduce any preferential 
orientation of the crystals.
7.3 Results and Discussion
7.3.1. Responses for the 19 CEH-Zinc-Pectinate Gelisphere Formulations
Table 7.3 illustrates the drug encapsulation efficiency, and dissolution values obtained 
after 6 hours (t6h). We postulated that on the basis of the plastically-deforming character 
of CEH, considerable reduction in drug release may be achieved. Our intention was to
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use the t6h value as a marker to indicate the degree of drug release suppression (Figure 
7.2).
Table 7.3 Response Outcomes for the 19 Formulations
CEH Gelisphere Number Drug Encapsulation Efficiency (%) Dissolution (%) at t6h
1 4.56 89.69
2 23.59 28.42
3 34.3 36.77
4 28.71 90.72
5 24.43 8.35
6 21.46 23.48
7 16.24 21.39
8 35.2 57.7
9 19.42 43.52
10 32.08 58.66
11 22.27 48.94
12 33.21 34.37
13 24.09 12.68
14 21.33 53.69
15 14.59 31.64
16 22.02 4.96
17 32.85 22.59
18 10.56 24.29
19 5.98 56.04
From Figure 7.2, it is apparent that the CEFI polymer, crosslinking reaction time and 
drying temperature produced significantly different drug release profiles. In order to 
isolate the factor that was more significant among the three, 4 optimization objectives 
were developed and predicted using Solver technology (Frontline Systems, USA) (Table 
7.4).
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Figure 7.2 Dissolution Profiles for (a) Formulations 1-5, (b) Formulations 6-10, (c) 
Formulations 11-15, and (d) Formulations 16-19. (In all cases it was observed that 
SDs<0.02 were obtained, N=3).
7.3.2 Statistical Optimization of the CEH-Zinc-Pectinate Gelisphere Matrices
Based on numerical optimization studies using forward and backward stepwise regression
the following equations were derived for the drug encapsulation efficiency and dissolution 
(at 6 hours):
Drug Encapsulation Efficiency = b0 + b1 *CEH + b2*CRT + b3*dT + b4*CEH*CEH + 
bs*CRT*CRT + b6*dT*dT + b7*CEH*CRT+ b8*CEH*dT + bg*CRT*dT (Equations 7.2)
Dissolution at tBh = b0 + b1 *CEH + b2*CRT + b3*dT + b4*CEH*CEH + bs*CRT*CRT + 
b6*dT*dT + b7*CEH*CRT+ bs*CEH*dT + b9*CRT*dT (Equation 7.3)
117
The optimization objectives were processed using the following rationale:
(i) Maximization of the drug encapsulation efficiency - Economic perspective,
(ii) Minimization of drug encapsulation efficiency - Reduce the diffusion gradient in the 
direction from the polymeric matrix towards the dissolution medium, hence reducing 
drug release,
(iii) Minimization of dissolution up to 6 hours (t6h) - Obtain an early phase of release rate- 
modulation, and
(iv) Maximization of dissolution up to 6 hours (t6h) - Used as a marker to evaluate the 
influence of CEH.
Objectives (ii) and (iii) above are intended to enhance the lag-phase seen in Figure 7.1. 
This may be beneficial for targeted drug delivery to the proximal and distal intestine, 
particularly if drugs are sensitive to the acidic gastric juice, demonstrate enhanced 
absorption in the intestine or are intended for the treatment of colonic disorders.
Table 7.4 indicates the necessary parameters to obtain solutions to Objectives (i)-(iv) after 
application of the Solver technology (Frontline Systems, USA). Note that no statistical 
significance (p>0.05) was observed between the predicted and experimental responses.
Table 7.4 Formulation Parameters to Obtain Selected Drug Encapsulation and 
Dissolution Properties______________________________________________________
Optimization
Solver-Predicted Formulation 
Parameters Solution (%)
Objective CEH
(%w/v)
CRT
(hours) dT (°C)
Predicted
Response
Experimental
Response
(0 0 13 60 35.84 (drug 
encapsulation 
efficiency)
28.63
(ii) 0.08 24 40 6.42 (drug 
encapsulation 
efficiency)
9.66
(iii) 0.10 24 40 2.31
(dissolution 
after t6h)
5.1
(iv) 0.02 24 20 90.74
(dissolution 
after t6h)
74.12
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Based on the above optimization objectives, the corresponding experimental dissolution 
profiles were obtained (Figure 7.3).
Figure 7.3 Dissolution profiles derived from Optimization Objectives (Table 7.4). (In 
all cases it was observed that SDs<0.14 were obtained, N=3).
From the above profiles it was apparent that the concentration of CEH together with the 
appropriate crosslinking reaction time and drying temperature, a range of drug release 
profiles may be tailor-made. In all cases zero-order drug delivery at different rates were 
produced. More interestingly, it was observed that as the concentration of CEFI was 
increased, a large lag time was introduced (4 hours), hence enabling prolonged delivery 
over several hours to days. This was a major improvement from the original zinc- 
pectinate profile seen in Figure 7.1 (0.5 hour lag-phase). In this regard, we propose that 
the CEFI-zinc-pectinate gelisphere system may be suitable for colonic drug delivery, or 
alternatively as a subcutaneous implant.
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7.3.3 Thermal and Molecular Disposition Properties
Figure 7.4a-c depicts typical DSC, FTIR and XRD profiles for a typical CEH-zinc-pectinate 
formulation. The following essential characteristics were observed:
(i) DSC: The glass transition temperature (Tg) of native PVA and pectin was found to be 
15°C and 20°C respectively. In addition, the melting endotherm of pure theophylline 
peaked at 272.77°C. The Tg value for the CEFI-zinc-pectinate complex appeared 
between 30°C to 35°C, indicating greater molecular mobility due to a transition into a 
more rubbery phase. This also explains the plastically-deforming nature of CEFI. The 
melting endotherm of theophylline was significantly reduced to =180°C in all 19 
formulations. This may be attributed to a significant interaction between the polymers, 
crosslinkers and drug (Figure 7.4a), hence weakening the inter-atomic bonds of the drug.
(ii) FTIR: These studies indicated that crosslinking markedly produced significant 
vibrations for aromatic C=C, C-H, N-H and C=0 groups. This is expected based on the 
individual molecular structures of native PVA and pectin. However, the extent of the 
vibrations was significantly suppressed based on the creation of a three-dimensional 
network (Figure 7.4b).
(Hi) XRD: These studies indicated that the crosslinked polymeric system was highly 
amorphous based on the typical bell-shaped curve (Figure 7.4c).
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(C)
Figure 7.4 Typical (a) DSC, (b) FTIR, and (c) XRD profiles for a CEH-zinc-pectinate 
formulation.
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7.4 Concluding Remarks
The new crosslinked ethylenic homopolymer (CEH) can be used as a time release rate- 
modulating excipient, rather than a traditional polymer. This crosslinking procedure is the 
first to be reported in this study based on the manipulation of previous incompatibilities of 
PVA with boric acid and sodium sulphate. The introduction of organic crosslinkers helped 
to facilitate this reaction.
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Conclusions and Recommendations
(i) Design of Experiments, employing a statistical and mathematical basis, is a useful 
approach to develop predictable and “intelligent” formulations for drug delivery.
(ii) Depending on the required resolution and sensitivity of the statistical output, 
sequential designs can be selected which use either linear or polynomial quadratic 
functions.
(iii) Polymeric materials in their existing form are capable of limited function. 
Expansion of their behaviour can be manipulated by rationally designed chemical 
interactions.
(iv) Crosslinking ionotropic reactions applied to polymeric materials enable strict 
control over matrix hydration, erosion, polymeric relaxation and disentanglement, 
and ultimately drug release rate.
(v) Based on the achievement of extended zero-order drug delivery using multiple-unit 
technology, this work is unique, since such reports in the literature are rare. Even 
with prolonged drug delivery from multiple-units described over the years, the 
duration is characteristically no longer than 8 hours. This work has provided a 
deliberate approach of extending drug release from hours to days.
(vi) The novel crosslinked ethylenic homopolymer (CEH) synthesized in this study is a 
potent material, based on the fact that very limited quantities are required for 
significant release rate-modulation.
In terms of future studies, it is recommended that the statistically-designed drug delivery 
systems developed in this work should be evaluated in vivo to ascertain the influence of 
physiological variables and subsequent pharmacokinetics. That study should first begin 
with an animal model to establish safety and efficacy, followed by investigations in healthy 
human volunteers. This will elucidate the true efficacy of these devices, which we 
anticipate would be superior drug carriers for common, yet currently incurable disorders, 
namely irritable bowel syndrome, musculo-skeletal deformations (e.g. arthritis) and
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pulmonary airway constriction (e.g. asthma).
Overall, we believe that this thesis has presented a significant contribution to the 
magnanimous database of pharmaceutical knowledge, and would be invaluable to 
scientists involved in drug design and delivery systems development.
In closing, while many scientists will embrace this work, others will challenge it. After all, 
it’s the only way to unveil the many mysteries in pharmaceutical sciences.
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